FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Schepers, E
   van Os, J
   Lousberg, R
AF Schepers, E.
   van Os, J.
   Lousberg, R.
TI White noise speech illusions in the general population: The association
   with psychosis expression and risk factors for psychosis
SO PLOS ONE
LA English
DT Article
ID SCHIZOPHRENIA; HALLUCINATIONS; METAANALYSIS; EXPERIENCES; RELIABILITY;
   ENVIRONMENT; INSTRUMENT; CAPE
AB Introduction
   Positive psychotic experiences are associated with increased rate of white noise speech illusions in patients and their relatives. However, findings have been conflicting to what degree speech illusions are associated with subclinical expression of psychosis in the general population. The aim of this study was to investigate the link between speech illusions and positive psychotic experiences in a general population sample. In addition, the hypothesis that speech illusions are on the pathway from known risk factors for psychosis (childhood adversity and recent life events) to subthreshold expression of psychosis, was examined.
   Methods
   In a follow-up design (baseline and 6 months) the association between the number of white noise speech illusions and self-reported psychotic experiences, assessed with the Community Assessment of Psychic Experiences (CAPE), was investigated in a general population sample (n = 112). In addition, associations between speech illusions and childhood adversity and life events, using the Childhood Experiences of Care and Abuse questionnaire and the Social Readjustment Rating Scale, were investigated.
   Results
   No association was found between the CAPE positive scale and the number of white noise speech illusions. The CAPE positive scale was significantly associated with childhood adversity between 12 and 16 years (B = 0.980 p = 0.001) and life events (B = 0.488 p = 0.044). The number of speech illusions showed no association with either life events or childhood adversity.
   Conclusion
   In the nonclinical population, the pathway from risk factors to expression of subclinical psychotic experiences does not involve white noise speech illusions as an intermediate outcome.
C1 [Schepers, E.; van Os, J.; Lousberg, R.] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, Maastricht, Netherlands.
   [van Os, J.] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London, England.
   [van Os, J.] Utrecht Univ Med Ctr, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.
RP Schepers, E (reprint author), Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, Maastricht, Netherlands.
EM e.schepers@student.maastrichtuniversity.nl
CR Aleman A, 2003, SCHIZOPHR RES, V64, P175, DOI 10.1016/S0920-9964(03)00060-4
   Beards S, 2013, SCHIZOPHRENIA BULL, V39, P740, DOI 10.1093/schbul/sbt065
   Behrendt RP, 1998, COMPR PSYCHIAT, V39, P236, DOI 10.1016/S0010-440X(98)90067-0
   Catalan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102520
   Collip D, 2008, SCHIZOPHRENIA BULL, V34, P220, DOI 10.1093/schbul/sbm163
   Daalman K, 2012, SCHIZOPHR RES, V139, P82, DOI 10.1016/j.schres.2012.06.005
   Dominguez MDG, 2010, AM J PSYCHIAT, V167, P1075, DOI 10.1176/appi.ajp.2010.09060883
   Eduardo Pedrero Fonseca, 2017, PSICOTHEMA, V29
   Galdos M, 2011, SCHIZOPHRENIA BULL, V37, P1179, DOI 10.1093/schbul/sbq029
   de Artaza MG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192373
   Hoffman RE, 2007, BRIT J PSYCHIAT, V191, P355, DOI 10.1192/bjp.bp.106.031195
   HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4
   Hugdahl K, 2009, SCAND J PSYCHOL, V50, P553, DOI 10.1111/j.1467-9450.2009.00775.x
   Kaymaz N, 2012, PSYCHOL MED, V42, P2239, DOI 10.1017/S0033291711002911
   Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x
   Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626
   Martin  Debbane, 2014, SCHIZOPHRENIA B S2, V41, pS396
   Mossaheb N, 2012, SCHIZOPHR RES, V141, P210, DOI 10.1016/j.schres.2012.08.008
   Pries LK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183695
   Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x
   Rimvall MK, 2016, PSYCHOL MED, V46, P2731, DOI 10.1017/S0033291716001112
   Smeets F, 2013, ACTA PSYCHIAT SCAND, V127, P34, DOI 10.1111/j.1600-0447.2012.01888.x
   van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814
   van Os J, 2016, WORLD PSYCHIATRY, V15, P118, DOI 10.1002/wps.20310
   van Os J, 2014, SCHIZOPHRENIA BULL, V40, P729, DOI 10.1093/schbul/sbu069
   van Rossum I, 2011, SCHIZOPHRENIA BULL, V37, P561, DOI 10.1093/schbul/sbp101
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482
NR 28
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 20
PY 2019
VL 14
IS 2
AR e0211914
DI 10.1371/journal.pone.0211914
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM2OT
UT WOS:000459307000045
PM 30785901
OA DOAJ Gold
DA 2019-06-25
ER

PT J
AU Vaessen, TSJ
   de Jong, L
   Schafer, AT
   Damen, T
   Uittenboogaard, A
   Krolinski, P
   Nwosu, CV
   Pinckaers, FME
   Rotee, ILM
   Smeets, APW
   Ermis, A
   Kennedy, JL
   Nieman, DH
   Tiwari, A
   van Os, J
   Drukker, M
AF Vaessen, Thomas Stephanus Johannes
   de Jong, Lea
   Schafer, Annika Theresia
   Damen, Thomas
   Uittenboogaard, Aniek
   Krolinski, Pauline
   Nwosu, Chinyere Vicky
   Pinckaers, Florentina Maria Egidius
   Rotee, Iris Leah Marije
   Smeets, Antonius Petrus Wilhelmus
   Ermis, Aysegui
   Kennedy, James L.
   Nieman, Dorien H.
   Tiwari, Arun
   van Os, Jim
   Drukker, Marjan
TI The interaction between cannabis use and the Val158Met polymorphism of
   the COMT gene in psychosis: A transdiagnostic meta - analysis
SO PLOS ONE
LA English
DT Article
ID O-METHYLTRANSFERASE GENE; ULTRA-HIGH-RISK; SUBSTANCE USE; SCHIZOPHRENIA;
   METAANALYSIS; EXPERIENCES; SYMPTOMS; GENOTYPE; ONSET; STATE
AB Background
   Neither environmental nor genetic factors are sufficient to predict the transdiagnostic expression of psychosis. Therefore, analysis of gene-environment interactions may be productive.
   Objective
   A meta-analysis was performed using papers investigating the interaction between cannabis use and catechol-O-methyl transferase (COMT) polymorphism Val158Met (COMTVal158Met).
   Data sources
   PubMed, Embase, PsychInfo.
   Study eligibility criteria
   All observational studies assessing the interaction between COMTVal158Met and cannabis with any psychosis or psychotic symptoms measure as an outcome.
   Study appraisal and synthesis methods
   A meta-analysis was performed using the Meta-analysis of Observational Studies in Epidemiology guidelines and forest plots were generated. Thirteen articles met the selection criteria: 7 clinical studies using a case-only design, 3 clinical studies with a dichotomous outcome, and 3 studies analysing a continuous outcome of psychotic symptoms below the threshold of psychotic disorder. The three study types were analysed separately. Validity of the included studies was assessed using "A Cochrane Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions".
   Results
   For case-only studies, a significant interaction was found between cannabis use and COMTVal158Met, with an OR of 1.45 (95% Confidence Interval = 1.05 +/- 2.00; Met/Met as the risk genotype). However, there was no evidence for interaction in either the studies including dichotomous outcomes (B = -0.51, 95% Confidence Interval -1.72, 0.70) or the studies including continuous outcomes (B = -0.04 95% Confidence Interval -0.16 +/- 0.08).
   Limitation
   A substantial part of the included studies used the case-only design, which has lower validity and tends to overestimate true effects.
   Conclusion
   The interaction term between cannabis use and COMTVal158Met was only statistically significant in the case-only studies, but not in studies using other clinical or non-clinical psychosis outcomes. Future additional high quality studies might change current perspectives, yet currently evidence for the interaction remains unconvincing.
C1 [Vaessen, Thomas Stephanus Johannes; de Jong, Lea; Schafer, Annika Theresia; Damen, Thomas; Uittenboogaard, Aniek; Krolinski, Pauline; Nwosu, Chinyere Vicky; Pinckaers, Florentina Maria Egidius; Rotee, Iris Leah Marije; Smeets, Antonius Petrus Wilhelmus] Maastricht Univ, Student Fac Hlth Med & Life Sci, Maastricht, Netherlands.
   [Ermis, Aysegui] Bakirkoy Mazhar Osman Mental Hlth & Neurol Dis Ed, Dept Psychiat, Istanbul, Turkey.
   [Kennedy, James L.; Tiwari, Arun] Campbell Family Mental Hlth Res Inst, Neurogenet Sect, Ctr Addict & Mental Hlth, Toronto, ON, Canada.
   [Nieman, Dorien H.] Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands.
   [van Os, Jim; Drukker, Marjan] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Psychol, Maastricht, Netherlands.
   [van Os, Jim] Univ Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Med Ctr, Utrecht, Netherlands.
   [van Os, Jim] Kings Coll London, Kings Hlth Partners Dept Psychosis Studies, London, England.
   [van Os, Jim] Kings Coll London, Inst Psychiat, London, England.
RP Drukker, M (reprint author), Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Psychol, Maastricht, Netherlands.
EM Marjan.Drukker@MaastrichtUniversity.nl
OI Smeets, Antonius/0000-0003-1868-3631
CR Albert PS, 2001, AM J EPIDEMIOL, V154, P687, DOI 10.1093/aje/154.8.687
   Alemany S, 2014, ACTA PSYCHIAT SCAND, V129, P54, DOI 10.1111/acps.12108
   [Anonymous], 2017, GENETICS MODIFY RESP
   Avramopoulos D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116696
   Batalla A, 2014, ADDICT BIOL, V19, P722, DOI 10.1111/adb.12027
   Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4
   Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026
   CHEN JP, 1990, EUR J PHARMACOL, V190, P259
   Costas J, 2011, SCHIZOPHR RES, V127, P22, DOI 10.1016/j.schres.2011.01.014
   De Sousa KR, 2013, SCHIZOPHR RES, V151, P289, DOI 10.1016/j.schres.2013.10.037
   Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ermis A, 2015, IN VIVO, V29, P129
   Estrada G, 2011, ACTA PSYCHIAT SCAND, V123, P485, DOI 10.1111/j.1600-0447.2010.01665.x
   Fadda P, 2006, NEUROREPORT, V17, P1629, DOI 10.1097/01.wnr.0000236853.40221.8e
   Fatjo-Vilas M, 2017, HANDBOOK OF CANNABIS AND RELATED PATHOLOGIES: BIOLOGY, PHARMACOLOGY, DIAGNOSIS, AND TREATMENT, pE29, DOI 10.1016/B978-0-12-800756-3.00031-4
   French L, 2015, JAMA PSYCHIAT, V72, P1002, DOI 10.1001/jamapsychiatry.2015.1131
   Glatt SJ, 2003, AM J PSYCHIAT, V160, P469, DOI 10.1176/appi.ajp.160.3.469
   Goes FS, 2015, AM J MED GENET B, V168, P649, DOI 10.1002/ajmg.b.32349
   Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889
   Green B, 2005, BRIT J PSYCHIAT, V187, P306, DOI 10.1192/bjp.187.4.306
   Gutierrez B, 2009, REV PSIQUIATR SALUD, V2, P89, DOI 10.1016/S1888-9891(09)72250-5
   Harrison PJ, 2015, J PSYCHOPHARMACOL, V29, P85, DOI 10.1177/0269881114553647
   Henquet C, 2009, ACTA PSYCHIAT SCAND, V119, P156, DOI 10.1111/j.1600-0447.2008.01265.x
   Iyegbe C, 2014, SOC PSYCH PSYCH EPID, V49, P169, DOI 10.1007/s00127-014-0823-2
   Jeppesen P, 2015, SCHIZOPHRENIA BULL, V41, P1084, DOI 10.1093/schbul/sbu167
   Kantrowitz JT, 2009, PSYCHIAT QUART, V80, P213, DOI 10.1007/s11126-009-9108-4
   Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13
   Kaymaz N, 2012, PSYCHOL MED, V42, P2239, DOI 10.1017/S0033291711002911
   Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x
   Kuepper R, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d738
   Laird NM, 2011, THE FUNDAMENTALS OF
   Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133
   Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626
   Mane A, 2015, PSYCHIAT RES, V229, P70, DOI 10.1016/j.psychres.2015.07.070
   Marcelis M, 1998, PSYCHOL MED, V28, P871, DOI 10.1017/S0033291798006898
   Messias EL, 2007, PSYCHIAT CLIN N AM, V30, P323, DOI 10.1016/j.psc.2007.04.007
   Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040
   Nieman DH, 2016, SCHIZOPHR RES, V174, P24, DOI 10.1016/j.schres.2016.03.015
   NIMH, 2015, SCHIZ FACT SHEET
   O'Tuathaigh CMP, 2010, NEUROPSYCHOPHARMACOL, V35, P2262, DOI 10.1038/npp.2010.100
   Pelayo-Teran JM, 2010, PSYCHIAT RES, V179, P291, DOI 10.1016/j.psychres.2009.08.022
   Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185
   Rognli EB, 2017, J SUBST ABUSE TREAT, V74, P42, DOI 10.1016/j.jsat.2016.12.007
   Russo EB, 2008, J EXP BOT, V59, P4171, DOI 10.1093/jxb/ern260
   Rutigliano G, 2016, J AFFECT DISORDERS, V203, P101, DOI 10.1016/j.jad.2016.05.053
   Simon AE, 2011, SCHIZOPHR RES, V132, P8, DOI 10.1016/j.schres.2011.07.002
   StataCorp, 2013, STAT STAT SOFTW REL
   Sterne J, 2014, A COCHRANE RISK OF B
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Trotta A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163319
   Tunbridge EM, 2015, J PSYCHOPHARMACOL
   van der Knaap LJ, 2014, GENES BRAIN BEHAV, V13, P618, DOI 10.1111/gbb.12147
   van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814
   van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117
   van Winkel R, 2014, ANNU REV CLIN PSYCHO, V10, P767, DOI 10.1146/annurev-clinpsy-032813-153631
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Verdoux H, 2002, SCHIZOPHR RES, V54, P59, DOI 10.1016/S0920-9964(01)00352-8
   Verrico CD, 2003, SYNAPSE, V49, P61, DOI 10.1002/syn.10215
   Vinkers CH, 2013, SCHIZOPHR RES, V150, P303, DOI 10.1016/j.schres.2013.07.020
   Williams HJ, 2007, SCHIZOPHRENIA BULL, V33, P635, DOI 10.1093/schbul/sbm019
   Yang QH, 1997, AM J EPIDEMIOL, V146, P713
   Yung A, 2005, AUST NZ J PSYCHIAT, V39, P67, DOI 10.1111/j.1440-1614.2005.01511.x
   Zammit S, 2007, BRIT J PSYCHIAT, V191, P402, DOI 10.1192/bjp.hp.107.036129
   Zammit S, 2011, BRIT J PSYCHIAT, V199, P380, DOI 10.1192/bjp.bp.111.091421
NR 65
TC 2
Z9 2
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 14
PY 2018
VL 13
IS 2
AR e0192658
DI 10.1371/journal.pone.0192658
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FW3CM
UT WOS:000425183500083
PM 29444152
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Naicker, SN
   Norris, SA
   Mabaso, M
   Richter, LM
AF Naicker, Sara N.
   Norris, Shane A.
   Mabaso, Musawenkosi
   Richter, Linda M.
TI An analysis of retrospective and repeat prospective reports of adverse
   childhood experiences from the South African Birth to Twenty Plus cohort
SO PLOS ONE
LA English
DT Article
ID SEXUAL-ABUSE; PHYSICAL ABUSE; MENTAL-HEALTH; RISK BEHAVIORS; HOUSEHOLD
   DYSFUNCTION; ADULT PSYCHOPATHOLOGY; ADOLESCENT REPORTS;
   SUICIDAL-BEHAVIOR; YOUNG-ADULTS; RELIABILITY
AB Most studies rely on cross-sectional retrospective reports from adult samples to collect information about adverse childhood experiences (ACEs) to examine relationships with adult outcomes. The problems associated with these reports have long been debated, with only a few studies determining their reliability and validity and fewer still reaching consensus on the matter. This paper uses repeat prospective and retrospective reports of adverse childhood experiences from two respondent sources in the South African Birth to Twenty Plus (Bt20+) cohort to explore agreement and concordance in the prospective reporting of ACEs by caregivers and respective children as adolescents and then as young adults. The findings demonstrate little overall agreement between prospective and retrospective accounts of childhood experiences, with 80% of kappa values below the moderate agreement cutoff (k =.41). The highest levels of agreement were found between prospective and retrospective reporting on parental and household death (kappas ranging from.519 to.944). Comparisons between prospective caregiver reports and retrospective young adult reports yielded high concordance rates on sexual and physical abuse and exposure to intimate partner violence (91.0%, 87.7% and 80.2%, respectively). The prevalence of reported ACEs varied with the age of the respondent, with adolescents reporting much higher rates of exposure to violence, physical and sexual abuse than are reported retrospectively or by caregivers. This variation may partly reflect actual changes in circumstances with maturation, but may be influenced by developmental stage and issues of memory, cognition and emotional state more than has been considered in previous analyses. More research, across disciplines, is needed to understand these processes and their effect on recall. Long-term prospective studies are critical for this purpose. In conclusion, methodological research that uses a range of information sources to establish the reliability and validity of both retrospective and prospective reports - recognizing that the two approaches may fundamentally answer different questions - should be encouraged.
C1 [Naicker, Sara N.] Human Sci Res Council, Human & Social Dev Programme, Kwa Zulu, South Africa.
   [Naicker, Sara N.; Norris, Shane A.; Richter, Linda M.] Univ Witwatersrand, MRC Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa.
   [Mabaso, Musawenkosi] Human Sci Res Council, HIV AIDS STIs &TB Programme, Kwa Zulu, South Africa.
   [Richter, Linda M.] Univ Witwatersrand, DST NRF Ctr Excellence Human Dev, Johannesburg, South Africa.
RP Naicker, SN (reprint author), Human Sci Res Council, Human & Social Dev Programme, Kwa Zulu, South Africa.; Naicker, SN (reprint author), Univ Witwatersrand, MRC Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa.
EM snaicker@hsrc.ac.za
FU Wellcome Trust (UK); Medical Research Council of South Africa; Human
   Sciences Research Council; University of the Witwatersrand; DST-NRF
   Centre of Excellence in Human Development at the University of the
   Witwatersrand, Johannesburg
FX The Bt20 study is funded by the Wellcome Trust (UK), the Medical
   Research Council of South Africa, the Human Sciences Research Council,
   the University of the Witwatersrand and supported by the DST-NRF Centre
   of Excellence in Human Development at the University of the
   Witwatersrand, Johannesburg.
CR Anda RF, 2002, PSYCHIAT SERV, V53, P1001, DOI 10.1176/appi.ps.53.8.1001
   Anda R, 2010, HEADACHE, V50, P1473, DOI 10.1111/j.1526-4610.2010.01756.x
   Banyard VL, 2001, J TRAUMA STRESS, V14, P697, DOI 10.1023/A:1013085904337
   Bifulco A, 1997, J CHILD PSYCHOL PSYC, V38, P365, DOI 10.1111/j.1469-7610.1997.tb01520.x
   Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8
   Brown DW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-20
   Brown DW, 2009, B WORLD HEALTH ORGAN, V87, P447, DOI 10.2471/BLT.07.047423
   Bruffaerts R, 2010, BRIT J PSYCHIAT, V197, P20, DOI 10.1192/bjp.bp.109.074716
   Clark C, 2010, ANN EPIDEMIOL, V20, P385, DOI 10.1016/j.annepidem.2010.02.008
   Cluver L, 2015, J ADOLESCENT HEALTH, V57, P52, DOI 10.1016/j.jadohealth.2015.03.001
   Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214
   De Mast J, 2007, AM STAT, V61, P148, DOI 10.1198/000313007X192392
   DiLillo D, 2006, ASSESSMENT, V13, P297, DOI 10.1177/1073191106288391
   Dill DL, 1991, COMPR PSYCHIAT, V32, P297
   Dong M, 2003, ARCH INTERN MED, V163, P1949, DOI 10.1001/archinte.163.16.1949
   Dong MX, 2004, CHILD ABUSE NEGLECT, V28, P771, DOI 10.1016/j.chiabu.2004.01.008
   Dube SR, 2004, CHILD ABUSE NEGLECT, V28, P729, DOI 10.1016/j.chiabu.2003.08.009
   Elstad JI, 2005, EUR J PUBLIC HEALTH, V15, P51, DOI 10.1093/eurpub/cki114
   Everson MD, 2008, CHILD MALTREATMENT, V13, P14, DOI 10.1177/1077559507307837
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8
   Fergusson DM, 2011, INT J METH PSYCH RES, V20, P93, DOI 10.1002/mpr.337
   Fergusson DM, 2000, PSYCHOL MED, V30, P529, DOI 10.1017/S0033291799002111
   FINLAYJONES R, 1981, AUST NZ J PSYCHIAT, V15, P27, DOI 10.3109/00048678109159406
   Fisher HL, 2011, CHILD ABUSE NEGLECT, V35, P117, DOI 10.1016/j.chiabu.2010.10.003
   Ford ES, 2011, PREV MED, V53, P188, DOI 10.1016/j.ypmed.2011.06.015
   Friedrich WN, 1997, CHILD MALTREATMENT, V2, P164, DOI DOI 10.1177/1077559597002002009
   Fry RPW, 1996, CHILD ABUSE NEGLECT, V20, P725, DOI 10.1016/0145-2134(96)00060-9
   Fuhrmann D, 2015, TRENDS COGN SCI, V19, P558, DOI 10.1016/j.tics.2015.07.008
   Soares ALG, 2016, CHILD ABUSE NEGLECT, V51, P21, DOI 10.1016/j.chiabu.2015.11.017
   Habermas T, 2000, PSYCHOL BULL, V126, P748, DOI 10.1037//0033-2909.126.5.748
   Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x
   Hardt J, 2006, J NERV MENT DIS, V194, P676, DOI 10.1097/01.nmd.0000235789.79491.1b
   Henry B., 1994, PSYCHOL ASSESSMENT, V6, P92, DOI DOI 10.1037/1040-3590.6.2.92
   Heusser S, 2014, S AFR J PSYCHOL, V44, P83, DOI 10.1177/0081246313516258
   Hillis SD, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e11
   Horwitz AV, 2001, J HEALTH SOC BEHAV, V42, P184, DOI 10.2307/3090177
   Hughes K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2906-3
   Janssen SMJ, 2008, Q J EXP PSYCHOL, V61, P1847, DOI 10.1080/17470210701774242
   Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027
   Jewkes RK, 2010, CHILD ABUSE NEGLECT, V34, P833, DOI 10.1016/j.chiabu.2010.05.002
   Jones DJ, 2010, J CLIN CHILD ADOLESC, V39, P667, DOI 10.1080/15374416.2010.501286
   Jones GT, 2009, PAIN, V143, P92, DOI 10.1016/j.pain.2009.02.003
   Kabiru Caroline W, 2010, Child Adolesc Psychiatry Ment Health, V4, P17, DOI 10.1186/1753-2000-4-17
   Kauhanen L, 2011, ADV PREVENTIVE MED, V2011, P1
   Kelly-Irving M, 2013, EUR J EPIDEMIOL, V28, P721, DOI 10.1007/s10654-013-9832-9
   Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499
   Kooiman CG, 2002, CHILD ABUSE NEGLECT, V26, P939, DOI 10.1016/S0145-2134(02)00363-0
   Kounou KB, 2012, SOC PSYCHIAT PSYCHIA, V48
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lansford JE, 2002, ARCH PEDIAT ADOL MED, V156, P824, DOI 10.1001/archpedi.156.8.824
   Leserman J, 1995, BEHAV MED, V21, P141, DOI 10.1080/08964289.1995.9933752
   LEWIS M, 1995, J AM ACAD CHILD PSY, V34, P405, DOI 10.1097/00004583-199504000-00007
   Lipschitz DS, 1999, J TRAUMA STRESS, V12, P641, DOI 10.1023/A:1024717117960
   MARTIN J, 1993, CHILD ABUSE NEGLECT, V17, P383, DOI 10.1016/0145-2134(93)90061-9
   McBeth J, 1999, J RHEMATOLOGY, V28, P2305
   Meade CS, 2012, DRUG ALCOHOL DEPEN, V126, P232, DOI 10.1016/j.drugalcdep.2012.05.024
   Meyer IH, 1996, CHILD ABUSE NEGLECT, V20, P213, DOI 10.1016/S0145-2134(95)00137-9
   Mills K, 2007, J TRAUMA STRESS, V20, P313, DOI 10.1002/jts.20219
   Offer D, 2000, J AM ACAD CHILD PSY, V39, P735, DOI 10.1097/00004583-200006000-00012
   Oladeji BD, 2010, BRIT J PSYCHIAT, V196, P186, DOI 10.1192/bjp.bp.109.063677
   PILLEMER DB, 1989, ADV CHILD DEV BEHAV, V21, P297, DOI 10.1016/S0065-2407(08)60291-8
   Pinto R, 2014, J FAM VIOLENCE, V29, P431, DOI 10.1007/s10896-014-9602-9
   Radford L, 2013, CHILD ABUSE NEGLECT, V37, P801, DOI 10.1016/j.chiabu.2013.02.004
   Ramiro LS, 2010, CHILD ABUSE NEGLECT, V34, P842, DOI 10.1016/j.chiabu.2010.02.012
   Raphael KG, 2001, PAIN, V92, P283, DOI 10.1016/S0304-3959(01)00270-6
   Reuben A, 2016, J CHILD PSYCHOL PSYC, V57, P1103, DOI 10.1111/jcpp.12621
   Reuchlein B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148162
   RICH CL, 1990, AM J PSYCHIAT, V147, P1389
   Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016
   Richter L, 2014, AIDS BEHAV, V18, P381, DOI 10.1007/s10461-013-0439-7
   Rothman K, 1998, MODERN EPIDEMIOLOGY
   Sacks V, 2014, RES BRIEF PUBLICATIO
   Schilling EA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-30
   Slopen N, 2010, SOC SCI MED, V71, P1847, DOI 10.1016/j.socscimed.2010.08.015
   Stein DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010574
   Swahn MH, 2006, AM J PUBLIC HEALTH, V96, P1849, DOI 10.2105/AJPH.2004.058230
   Tajima EA, 2004, AM J ORTHOPSYCHIAT, V74, P424, DOI 10.1037/0002-9432.74.4.424
   Thomas C, 2008, PEDIATRICS, V121, pE1240, DOI 10.1542/peds.2007-2403
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Whitaker RC, 2014, PREV MED, V67, P147, DOI 10.1016/j.ypmed.2014.07.029
   White HR, 2007, PSYCHOL REP, V101, P1079, DOI 10.2466/PR0.101.4.1079-1094
   Widom CS, 2004, CHILD ABUSE NEGLECT, V28, P715, DOI 10.1016/j.chiabu.2004.03.009
   Widom CS, 1999, J CONSULT CLIN PSYCH, V67, P867, DOI 10.1037//0022-006X.67.6.867
   Widom CS, 1997, PSYCHOL ASSESSMENT, V9, P34, DOI 10.1037/1040-3590.9.1.34
   WILLIAMS LM, 1995, J TRAUMA STRESS, V8, P649, DOI 10.1002/jts.2490080408
   WILLIAMS LM, 1994, J CONSULT CLIN PSYCH, V62, P1167, DOI 10.1037//0022-006X.63.3.343
   Williams SL, 2007, J TRAUMA STRESS, V20, P845, DOI 10.1002/jts.20252
   Wise LA, 2001, LANCET, V358, P881, DOI 10.1016/S0140-6736(01)06072-X
   World Health Organization, 2014, SURV PREV ADV CHILD
   Yancura LA, 2009, PSYCHOL AGING, V24, P715, DOI 10.1037/a0016203
NR 90
TC 7
Z9 8
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 26
PY 2017
VL 12
IS 7
AR e0181522
DI 10.1371/journal.pone.0181522
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FB8EN
UT WOS:000406371800040
PM 28746343
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Kilian, S
   Burns, JK
   Seedat, S
   Asmal, L
   Chiliza, B
   Du Plessis, S
   Olivier, MR
   Kidd, M
   Emsley, R
AF Kilian, S.
   Burns, J. K.
   Seedat, S.
   Asmal, L.
   Chiliza, B.
   Du Plessis, S.
   Olivier, M. R.
   Kidd, M.
   Emsley, R.
TI Factors Moderating the Relationship Between Childhood Trauma and
   Premorbid Adjustment in First-Episode Schizophrenia
SO PLOS ONE
LA English
DT Article
ID PSYCHOSIS PATIENTS; HIGH-RISK; MALTREATMENT; SYMPTOMS; STRESS; CHILDREN;
   ABUSE; QUESTIONNAIRE; DISSOCIATION; ADOLESCENCE
AB Childhood trauma is a recognised risk factor for schizophrenia. It has been proposed that childhood trauma interferes with normal neurodevelopment, thereby establishing a biological vulnerability to schizophrenia. Poor premorbid adjustment is frequently a precursor to schizophrenia, and may be a manifestation of neurodevelopmental compromise. We investigated the relationship between childhood trauma and premorbid adjustment in 77 patients with first-episode schizophrenia spectrum disorders. We also investigated possible mediating roles for other selected risk factors in the relationship. We found several significant correlations between different trauma types and both social and academic premorbid adjustment from childhood to late adolescence. There were no significant moderating effects for family history of schizophrenia or family history of psychiatric disorder. History of obstetric complications, substance abuse and poor motor coordination weakened some of the associations between childhood trauma and premorbid adjustment, while poor sequencing of motor acts strengthened the association. Our results confirm previous studies indicating an association between childhood trauma and premorbid adjustment. Results indicate a general rather than specific association, apparent with different types of trauma, and affecting both social and academic components of premorbid adjustment across childhood, early and late adolescence. Further, our results suggest a complex interplay of various risk factors, supporting the notion of different pathways to psychosis.
C1 [Kilian, S.; Seedat, S.; Asmal, L.; Chiliza, B.; Du Plessis, S.; Olivier, M. R.; Emsley, R.] Univ Stellenbosch, Dept Psychiat, Cape Town, South Africa.
   [Burns, J. K.] Univ KwaZulu Natal, Dept Psychiat, Durban, South Africa.
   [Burns, J. K.] Univ Exeter, Inst Hlth Res, Exeter, Devon, England.
   [Kidd, M.] Univ Stellenbosch, Ctr Stat Consultat, Cape Town, South Africa.
EM sanjak@sun.ac.za
OI Kilian, Sanja/0000-0003-4649-8388
FU New Partnership for Africa's Development (NEPAD) grant, through the
   Department of Science and Technology of South Africa; Medical Research
   Council of South Africa; Lundbeck International
FX This study was funded by a New Partnership for Africa's Development
   (NEPAD) grant, through the Department of Science and Technology of South
   Africa, the Medical Research Council of South Africa and an unrestricted
   grant from Lundbeck International.
CR Aas M, 2011, SCHIZOPHR RES, V129, P12, DOI 10.1016/j.schres.2011.03.017
   Alameda L, 2015, PSYCHOL MED, V45, P2727, DOI 10.1017/S0033291715000690
   Allen DN, 2013, SCHIZOPHR RES, V146, P132, DOI 10.1016/j.schres.2013.01.032
   Bendall S, 2013, EARLY INTERV PSYCHIA, V7, P1, DOI 10.1111/eip.12008
   Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0
   Bernstein DP, 1998, CTQ CHILDHOOD TRAUMA
   Braehler C, 2013, PSYCHIAT RES, V210, P36, DOI 10.1016/j.psychres.2013.05.033
   Buchanan RQ, 1998, PSYCHIAT RES, V21, P335
   CANNONSPOOR HE, 1982, SCHIZOPHRENIA BULL, V8, P470, DOI 10.1093/schbul/8.3.470
   Conus P, 2010, J AFFECT DISORDERS, V124, P341, DOI 10.1016/j.jad.2009.12.021
   Demjaha A, 2012, SCHIZOPHRENIA BULL, V38, P209, DOI 10.1093/schbul/sbr100
   Fergusson DM, 2011, INT J METH PSYCH RES, V20, P93, DOI 10.1002/mpr.337
   First M. B., 2002, COMMUNICATION
   Glaser JP, 2006, J PSYCHOSOM RES, V61, P229, DOI 10.1016/j.jpsychores.2006.04.014
   Gupta Swapnil, 2010, Indian J Psychiatry, V52, P21, DOI 10.4103/0019-5545.58891
   Harley M, 2010, PSYCHOL MED, V40, P1627, DOI 10.1017/S0033291709991966
   Houston JE, 2011, PSYCHOL MED, V41, P2339, DOI 10.1017/S0033291711000559
   Jonson-Reid M, 2004, CHILD MALTREATMENT, V9, P382, DOI 10.1177/1077559504269192
   Krabbendam L, 2008, PSYCHOL MED, V38, P1405, DOI 10.1017/S0033291708002705
   Lowe SR, 2016, CHILD ABUSE NEGLECT, V51, P212, DOI 10.1016/j.chiabu.2015.10.007
   Maguire SA, 2015, CHILD CARE HLTH DEV, V41, P641, DOI 10.1111/cch.12227
   MURRAY RM, 1992, J PSYCHIAT RES, V26, P225, DOI 10.1016/0022-3956(92)90029-N
   Murray Robin M, 2002, World Psychiatry, V1, P137
   Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005
   Norman RMG, 2005, ACTA PSYCHIAT SCAND, V112, P30, DOI 10.1111/j.1600-0447.2005.00555.x
   Perzow SED, 2013, J TRAUMA DISSOCIATIO, V14, P302, DOI 10.1080/15299732.2012.736928
   Petruzzelli MG, 2015, NEUROPSYCH DIS TREAT, V11, P1793, DOI 10.2147/NDT.S83904
   Quee PJ, 2014, J ABNORM PSYCHOL, V123, P578, DOI 10.1037/a0037189
   Ramsay CE, 2011, PSYCHIAT RES, V188, P343, DOI 10.1016/j.psychres.2011.05.019
   SANDERS B, 1991, AM J PSYCHIAT, V148, P50
   Schafer I, 2006, J NERV MENT DIS, V194, P135, DOI 10.1097/01.nmd.0000198199.57512.84
   Schenkel LS, 2005, SCHIZOPHR RES, V76, P273, DOI 10.1016/j.schres.2005.03.003
   Sideli L., 2015, EARLY INTERV PSYCHIA
   Stain HJ, 2014, SCHIZOPHRENIA BULL, V40, P1491, DOI 10.1093/schbul/sbt166
   Tarbox SI, 2012, SCHIZOPHR RES, V141, P91, DOI 10.1016/j.schres.2012.07.008
   Thompson AD, 2014, SCHIZOPHRENIA BULL, V40, P697, DOI 10.1093/schbul/sbt032
   Tikka M, 2013, EARLY INTERV PSYCHIA, V7, P51, DOI 10.1111/j.1751-7893.2012.00391.x
   Trauelsen A. M., 2016, AUST NZ J PSYCHIAT, V2016, P1, DOI DOI 10.1016/LPSYCHRES.2016.02.003
   Trotta A, 2015, BJPSYCH OPEN, V1, P6, DOI 10.1192/bjpo.bp.115.000158
   Ucok A, 2007, ACTA PSYCHIAT SCAND, V116, P371, DOI 10.1111/j.1600-0447.2007.01079.x
   van Winkel R, 2008, SCHIZOPHRENIA BULL, V34, P1095, DOI 10.1093/schbul/sbn101
   Varambally Shivarama, 2012, Indian J Psychiatry, V54, P73, DOI 10.4103/0019-5545.94653
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Viola TW, 2016, CHILD ABUSE NEGLECT, V51, P1, DOI 10.1016/j.chiabu.2015.11.019
   Wang Z, 2013, EARLY INTERV PSYCHIA, V7, P23, DOI 10.1111/j.1751-7893.2012.00387.x
NR 45
TC 5
Z9 5
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 20
PY 2017
VL 12
IS 1
AR e0170178
DI 10.1371/journal.pone.0170178
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI3QC
UT WOS:000392405300081
PM 28107388
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Trotta, A
   Iyegbe, C
   Di Forti, M
   Sham, PC
   Campbell, DD
   Cherny, SS
   Mondelli, V
   Aitchison, KJ
   Murray, RM
   Vassos, E
   Fisher, HL
AF Trotta, Antonella
   Iyegbe, Conrad
   Di Forti, Marta
   Sham, Pak C.
   Campbell, Desmond D.
   Cherny, Stacey S.
   Mondelli, Valeria
   Aitchison, Katherine J.
   Murray, Robin M.
   Vassos, Evangelos
   Fisher, Helen L.
TI Interplay between Schizophrenia Polygenic Risk Score and Childhood
   Adversity in First-Presentation Psychotic Disorder: A Pilot Study
SO PLOS ONE
LA English
DT Article
ID ABUSE QUESTIONNAIRE CECA.Q; FAMILIAL RISK; TRAUMA; ASSOCIATION;
   ENVIRONMENT; PSYCHOPATHOLOGY; STRATIFICATION; METAANALYSIS; VALIDATION;
   EXPERIENCE
AB A history of childhood adversity is associated with psychotic disorder, with an increase in risk according to number or severity of exposures. However, it is not known why only some exposed individuals go on to develop psychosis. One possibility is pre-existing genetic vulnerability. Research on gene-environment interaction in psychosis has primarily focused on candidate genes, although the genetic effects are now known to be polygenic. This pilot study investigated whether the effect of childhood adversity on psychosis is moderated by the polygenic risk score for schizophrenia (PRS). Data were utilised from the Genes and Psychosis (GAP) study set in South London, UK. The GAP sample comprises 285 first-presentation psychosis cases and 256 unaffected controls with information on childhood adversity. We studied only white subjects (80 cases and 110 controls) with PRS data, as the PRS has limited predictive ability in patients of African ancestry. The occurrence of childhood adversity was assessed with the Childhood Experience of Care and Abuse Questionnaire (CECA.Q) and the PRS was based on genome-wide meta-analysis results for schizophrenia from the Psychiatric Genomics Consortium. Higher schizophrenia PRS and childhood adversities each predicted psychosis status. Nevertheless, no evidence was found for interaction as departure from additivity, indicating that the effect of polygenic risk scores on psychosis was not increased in the presence of a history of childhood adversity. These findings are compatible with a multifactorial threshold model in which both genetic liability and exposure to environmental risk contribute independently to the etiology of psychosis.
C1 [Trotta, Antonella; Iyegbe, Conrad; Murray, Robin M.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England.
   [Di Forti, Marta; Aitchison, Katherine J.; Vassos, Evangelos; Fisher, Helen L.] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England.
   [Sham, Pak C.; Campbell, Desmond D.; Cherny, Stacey S.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.
   [Sham, Pak C.; Campbell, Desmond D.; Cherny, Stacey S.] Univ Hong Kong, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China.
   [Mondelli, Valeria] Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, London, England.
   [Aitchison, Katherine J.] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada.
   [Aitchison, Katherine J.] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.
RP Fisher, HL (reprint author), Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England.
EM helen.2.fisher@kcl.ac.uk
RI murray, robin/F-8658-2012; Aitchison, Katherine/G-4476-2013; Cherny,
   Stacey/B-3315-2008
OI murray, robin/0000-0003-0829-0519; Mondelli,
   Valeria/0000-0001-8690-6839; Aitchison, Katherine/0000-0002-1107-3024;
   Di Forti, Marta/0000-0002-3218-6925; Cherny, Stacey/0000-0002-0269-3352;
   Campbell, Desmond/0000-0003-1085-714X
FU Maudsley Charitable Fund; United Kingdom (UK) National Institute of
   Health Research (NIHR) Specialist Biomedical Research Centre for Mental
   Health grant (BRC-SLAM); NIHR BRC-SLAM; Psychiatry Research Trust
   studentship; Brain & Behaviour Research Foundation [22604]; UK Medical
   Research Council Population Health Scientist award [G1002366]; MQ:
   Transforming Mental Health Fellows Award [MQ14F40]; Government of
   Alberta; Academy of Medical Sciences (AMS) [AMS-SGCL5-Mondelli]; Medical
   Research Council [G1002366]; National Institute for Health Research
   [608]
FX The work was supported by the Maudsley Charitable Fund and the United
   Kingdom (UK) National Institute of Health Research (NIHR) Specialist
   Biomedical Research Centre for Mental Health grant (BRC-SLAM). RMM
   receives salary support from the NIHR BRC-SLAM. AT was funded by a
   Psychiatry Research Trust studentship. CI is funded by a NARSAD Young
   Investigator award [22604] from the Brain & Behaviour Research
   Foundation. HLF was funded by a UK Medical Research Council Population
   Health Scientist award [G1002366] and an MQ: Transforming Mental Health
   Fellows Award [MQ14F40]. KJA holds an Alberta Centennial Addiction and
   Mental Health Research Chair, funded by the Government of Alberta. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aas M, 2014, J PSYCHIATR RES, V59, P14, DOI 10.1016/j.jpsychires.2014.08.011
   Aas M, 2013, PROG NEURO-PSYCHOPH, V46, P181, DOI 10.1016/j.pnpbp.2013.07.008
   Ajnakina O, 2016, PSYCHOL MED, V46, P317, DOI 10.1017/S0033291715001816
   Ajnakina O, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00084
   Alemany S, 2013, EUR PSYCHIAT, V28, P207, DOI 10.1016/j.eurpsy.2012.03.001
   [Anonymous], 1994, SCHED CLIN ASS NEUR
   Arseneault L, 2011, AM J PSYCHIAT, V168, P65, DOI 10.1176/appi.ajp.2010.10040567
   Asarnow RF, 2001, ARCH GEN PSYCHIAT, V58, P581, DOI 10.1001/archpsyc.58.6.581
   Beards S, 2013, SCHIZOPHRENIA BULL, V39, P740, DOI 10.1093/schbul/sbt065
   BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11
   Bifulco A, 2005, BRIT J CLIN PSYCHOL, V44, P563, DOI 10.1348/014466505X35344
   Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2
   Collip D, 2013, BRIT J PSYCHIAT, V202, P261, DOI 10.1192/bjp.bp.112.115972
   DELLAFEMINA D, 1990, CHILD ABUSE NEGLECT, V14, P227
   DEUTCH AY, 1990, BRAIN RES, V521, P311, DOI 10.1016/0006-8993(90)91557-W
   Di Forti M, 2009, BRIT J PSYCHIAT, V195, P488, DOI 10.1192/bjp.bp.109.064220
   Fisher HL, 2011, SCHIZOPHRENIA BULL, V37, P546, DOI 10.1093/schbul/sbp103
   Fisher HL, 2014, SCHIZOPHRENIA BULL, V40, P1443, DOI 10.1093/schbul/sbt201
   Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269
   Green MJ, 2014, J PSYCHIATR RES, V49, P43, DOI 10.1016/j.jpsychires.2013.10.018
   Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x
   Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531
   Iyegbe C, 2014, SOC PSYCH PSYCH EPID, V49, P169, DOI 10.1007/s00127-014-0823-2
   Jaffee SR, 2012, DEV PSYCHOPATHOL, V24, P1253, DOI 10.1017/S0954579412000685
   Kapur S, 2005, SCHIZOPHR RES, V79, P59, DOI 10.1016/j.schres.2005.01.003
   Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006
   Kendler KS, 2010, BRIT J PSYCHIAT, V197, P170, DOI 10.1192/bjp.bp.110.081331
   Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157
   McCrory Eamon, 2011, Front Psychiatry, V2, P48, DOI 10.3389/fpsyt.2011.00048
   MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764
   Meyers JL, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.63
   Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473
   Mullins N, 2016, PSYCHOL MED, V46, P759, DOI 10.1017/S0033291715002172
   Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137
   Peyrot WJ, 2014, BRIT J PSYCHIAT, V205, P113, DOI 10.1192/bjp.bp.113.143081
   Pfeifer S, 2010, PSYCHOSIS, V2, P1, DOI 10.1080/17522430903197384
   Porta MS, 2008, DICT EPIDEMIOLOGY
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185
   Radford L, 2013, CHILD ABUSE NEGLECT, V37, P801, DOI 10.1016/j.chiabu.2013.02.004
   Rajkumar RP, 2014, MED HYPOTHESES, V83, P276, DOI 10.1016/j.mehy.2014.05.017
   Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   Salvatore JE, 2014, GENES-BASEL, V5, P330, DOI 10.3390/genes5020330
   Schafer Ingo, 2011, Dialogues Clin Neurosci, V13, P360
   Shevlin M, 2008, SCHIZOPHRENIA BULL, V34, P193, DOI 10.1093/schbul/sbm069
   Smith N, 2002, SOC PSYCH PSYCH EPID, V37, P572, DOI 10.1007/s00127-002-0589-9
   Sullivan PF, 2012, NAT MED, V18, P210, DOI 10.1038/nm.2670
   Trotta A, 2016, SCHIZOPHRENIA BULL, V42, P464, DOI 10.1093/schbul/sbv131
   Trotta A, 2015, BJPSYCH OPEN, V1, P6, DOI 10.1192/bjpo.bp.115.000158
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Vassos E, 2017, BIOL PSYCHIAT, V81, P470, DOI 10.1016/j.biopsych.2016.06.028
   Vinkhuyzen AAE, 2015, EPIDEMIOL PSYCH SCI, V24, P12, DOI 10.1017/S2045796014000584
   Wickrama K, 2014, J YOUTH ADOLESCENCE, V43, P1096, DOI 10.1007/s10964-014-0109-8
   Wigman JTW, 2012, ACTA PSYCHIAT SCAND, V126, P266, DOI 10.1111/j.1600-0447.2012.01857.x
   World Health Organisation, 1992, ICD 10 CLASS MENT BE
   Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457
   Wray NR, 2010, SCHIZOPHRENIA BULL, V36, P14, DOI 10.1093/schbul/sbp137
   Zammit S, 2010, BRIT J PSYCHIAT, V197, P207, DOI 10.1192/bjp.bp.109.070904
NR 59
TC 13
Z9 13
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 20
PY 2016
VL 11
IS 9
AR e0163319
DI 10.1371/journal.pone.0163319
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DW8GE
UT WOS:000383892100079
PM 27648571
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Cristobal-Narvaez, P
   Sheinbaum, T
   Rosa, A
   Ballespi, S
   de Castro-Catala, M
   Pena, E
   Kwapil, TR
   Barrantes-Vidal, N
AF Cristobal-Narvaez, Paula
   Sheinbaum, Tamara
   Rosa, Araceli
   Ballespi, Sergi
   de Castro-Catala, Marta
   Pena, Elionora
   Kwapil, Thomas R.
   Barrantes-Vidal, Neus
TI The Interaction between Childhood Bullying and the FKBP5 Gene on
   Psychotic-Like Experiences and Stress Reactivity in Real Life
SO PLOS ONE
LA English
DT Article
ID SOCIAL DEFEAT; ENVIRONMENT INTERACTION; HIGH-RISK; TRAUMA; SCHIZOTYPY;
   SCHIZOPHRENIA; METAANALYSIS; ASSOCIATION; SYMPTOMS; DISORDER
AB Aim
   The present study employed Experience Sampling Methodology to examine whether the interaction between childhood bullying and FKBP5 variability (i) is associated with the expression of psychotic-like experiences, paranoia, and negative affect, and (ii) moderates psychotic-like, paranoid, and affective reactivity to different forms of momentary stress (situational and social) in daily life.
   Methods
   A total of 206 nonclinical young adults were interviewed for bullying with the Childhood Experience of Care and Abuse and were prompted randomly eight times daily for one week to complete assessments of their current experiences, affect, and stress appraisals. Participants were genotyped for three FKBP5 single nucleotide polymorphisms (SNPs) (rs3800373, rs9296158, and rs1360780) that have been linked to hypothalamus-pituitary-adrenal axis reactivity. Multilevel analyses were conducted to examine the effect of the interaction between childhood bullying and the FKBP5 haplotype derived from these three SNPs.
   Results
   The interaction between bullying and the FKBP5 haplotype was associated with positive, but not negative, psychotic-like experiences, paranoia, and negative affect. The bullying x FKBP5 interaction also moderated the association of a social stress appraisal (specifically, being alone because people do not want to be with you) with psychotic-like experiences and negative affect in daily life. Simple slopes analyses indicated that, in all cases, the associations were significantly increased by exposure to bullying in participants with the risk haplotype, but not for those with the non-risk haplotype. D
   iscussion
   The present study provides the first evidence of the interplay between childhood bullying and FKBP5 variability in the real-world expression of psychosis proneness and social stress reactivity. The findings underscore the importance of investigating how gene-environment interactions are involved in mechanistic pathways to the extended psychosis phenotype and lend further support to the increasing relevance given to socially defeating appraisals in the experience of reality distortion.
C1 [Cristobal-Narvaez, Paula; Sheinbaum, Tamara; Ballespi, Sergi; Barrantes-Vidal, Neus] Univ Autonoma Barcelona, Dept Psicol Clin & Salut, Barcelona, Spain.
   [Rosa, Araceli; de Castro-Catala, Marta; Pena, Elionora] Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Seccio Zool & Antropol, Barcelona, Spain.
   [Rosa, Araceli; Barrantes-Vidal, Neus] Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain.
   [Rosa, Araceli; de Castro-Catala, Marta; Pena, Elionora] IBUB, Barcelona, Spain.
   [Kwapil, Thomas R.; Barrantes-Vidal, Neus] UNCG, Dept Psychol, Greensboro, NC USA.
   [Barrantes-Vidal, Neus] St Pere Claver Fundacio Sanit, Barcelona, Spain.
RP Barrantes-Vidal, N (reprint author), Univ Autonoma Barcelona, Dept Psicol Clin & Salut, Barcelona, Spain.; Barrantes-Vidal, N (reprint author), Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain.; Barrantes-Vidal, N (reprint author), UNCG, Dept Psychol, Greensboro, NC USA.; Barrantes-Vidal, N (reprint author), St Pere Claver Fundacio Sanit, Barcelona, Spain.
EM neus.barrantes@uab.cat
RI de Castro-Catala, Marta/E-2246-2019; Cristobal-Narvaez,
   Paula/K-3265-2017; Ballespi, Sergi/L-6492-2014; Kwapil, Thomas
   R./L-1127-2014; Kwapil, Thomas/I-3163-2019; Barrantes-Vidal,
   Neus/A-9578-2013; Rosa, Araceli/Q-2099-2016; Sheinbaum,
   Tamara/A-8008-2016
OI de Castro-Catala, Marta/0000-0002-5550-4885; Cristobal-Narvaez,
   Paula/0000-0001-8184-6347; Ballespi, Sergi/0000-0002-6584-4138; Kwapil,
   Thomas R./0000-0003-1116-5954; Barrantes-Vidal,
   Neus/0000-0002-8671-1238; Rosa, Araceli/0000-0001-6935-3785; Sheinbaum,
   Tamara/0000-0002-2268-7697
FU Spanish Ministerio de Economia y Competitividad (Plan Nacional de I+D)
   [PSI2014-54009-R, PSI2011-30321-C02-01, PSI2011-30321-C02-02]; Spanish
   Ministerio de Economia y Competitividad (Red de Excelencia PROMOSAM)
   [PSI2014-56303-REDT]; Fundacio La Marato de TV3 [091110]; Generalitat de
   Catalunya (Suport als Grups de Recerca) [2014SGR1070, 2014SGR1636];
   Institucio Catalana de Recerca i Estudis Avancats (ICREA), ICREA
   Academia Award
FX This work was supported by the Spanish Ministerio de Economia y
   Competitividad (Plan Nacional de I+D PSI2014-54009-R,
   PSI2011-30321-C02-01 and C02-02, and Red de Excelencia PROMOSAM
   PSI2014-56303-REDT), Fundacio La Marato de TV3 (091110), and Generalitat
   de Catalunya (Suport als Grups de Recerca 2014SGR1070 and 2014SGR1636).
   NBV is supported by the Institucio Catalana de Recerca i Estudis
   Avancats (ICREA), ICREA Academia Award. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ajnakina O, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00084
   Alemany S, 2016, PSYCHOL MED, V46, P221, DOI 10.1017/S0033291715001695
   Arseneault L, 2011, AM J PSYCHIAT, V168, P65, DOI 10.1176/appi.ajp.2010.10040567
   Barrantes-Vidal N, 2015, SCHIZOPHRENIA BULL, V41, pS408, DOI 10.1093/schbul/sbu191
   Barrantes-Vidal N, 2013, J ABNORM PSYCHOL, V122, P1077, DOI 10.1037/a0034793
   Barrantes-Vidal N, 2013, SCHIZOPHR RES, V145, P50, DOI 10.1016/j.schres.2013.01.007
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x
   Bifulco A., 2013, UNDERSTANDING ADULT
   Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI [10.1016/j.psyneuen.2008.08.018, 10.1016/j.psyneuen.2009.05.021]
   Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479
   Bjorkqvist K, 2001, PHYSIOL BEHAV, V73, P435, DOI 10.1016/S0031-9384(01)00490-5
   Bolger N, 2013, INTENSIVE LONGITUDIN
   Chun CA, 2017, PERSONAL DISORD, V8, P64, DOI 10.1037/per0000141
   Collip D, 2013, BRIT J PSYCHIAT, V202, P261, DOI 10.1192/bjp.bp.112.115972
   Conner TS, 2009, SOC PERSONAL PSYCHOL, V3, P292, DOI 10.1111/j.1751-9004.2009.00170.x
   Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540
   Cristobal-Narvaez P, IMPACT OF ADVERSE CH
   Daskalakis NP, 2015, SCHIZOPHRENIA BULL, V41, P323, DOI 10.1093/schbul/sbu189
   Ellsworth KA, 2013, PHARMACOGENET GENOM, V23, P156, DOI 10.1097/FPC.0b013e32835dc133
   Gawlik M, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-52
   Hammels C, 2015, NEUROSCI BIOBEHAV R, V59, P111, DOI 10.1016/j.neubiorev.2015.10.006
   Hartmann J, 2012, PSYCHONEUROENDOCRINO, V37, P2009, DOI 10.1016/j.psyneuen.2012.04.017
   Hektner J. M., 2007, EXPERIENCE SAMPLING
   Hernaus D, 2015, J ABNORM PSYCHOL, V124, P27, DOI 10.1037/abn0000010
   Kelleher I, 2013, AM J PSYCHIAT, V170, P734, DOI 10.1176/appi.ajp.2012.12091169
   Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006
   Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275
   Kwapil TR, 2012, PSYCHOL MED, V42, P2555, DOI 10.1017/S0033291712000827
   Kwapil TR, 2015, SCHIZOPHRENIA BULL, V41, pS366, DOI 10.1093/schbul/sbu186
   Matheson SL, 2013, PSYCHOL MED, V43, P225, DOI 10.1017/S0033291712000785
   Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473
   Muthen L, 1998, MPLUS USERS GUIDE
   Myin-Germeys I, 2003, CURR OPIN PSYCHIATR, V16, pS33, DOI 10.1097/00001504-200304002-00006
   Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947
   Nezlek J. B, 2011, MULTILEVEL MODELING
   OLWEUS D, 1994, J CHILD PSYCHOL PSYC, V35, P1171, DOI 10.1111/j.1469-7610.1994.tb01229.x
   Oorschot M, 2009, PSYCHOL ASSESSMENT, V21, P498, DOI 10.1037/a0017077
   Ostrov JM, 2015, J CLIN CHILD ADOLESC, V44, P509, DOI 10.1080/15374416.2015.1012723
   Palmier-Claus JE, 2012, PSYCHOL MED, V42, P1003, DOI 10.1017/S0033291711001929
   Parker J. G., 2006, DEV PSYCHOPATHOL, P419, DOI [10.1002/9780470939383.ch12, DOI 10.1002/9780470939383.CH12]
   Raudenbush S. W., 2013, HLM 7 01 FOR WINDOWS
   Reininghaus U, SCHIZOPHR BULL IN PR
   Selten JP, 2013, SCHIZOPHRENIA BULL, V39, P1180, DOI 10.1093/schbul/sbt134
   Sheinbaum T., 2015, SCHIZOTYPY NEW DIMEN, P116
   Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378
   Valmaggia LR, 2015, SCHIZOPHR RES, V168, P16, DOI 10.1016/j.schres.2015.07.050
   van Dam DS, 2012, PSYCHOL MED, V42, P2463, DOI 10.1017/S0033291712000360
   van Nierop M, 2014, ACTA PSYCHIAT SCAND, V129, P467, DOI 10.1111/acps.12212
   van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814
   van Winkel M, 2014, EUR NEUROPSYCHOPHARM, V24, P930, DOI 10.1016/j.euroneuro.2014.02.005
   van Winkel R, 2008, SCHIZOPHRENIA BULL, V34, P1095, DOI 10.1093/schbul/sbn101
   van Winkel R, 2013, CAN J PSYCHIAT, V58, P44, DOI 10.1177/070674371305800109
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Velikonja T, 2015, PSYCHOL MED, V45, P947, DOI 10.1017/S0033291714002086
   Wichers M, 2014, PSYCHOL MED, V44, P1349, DOI 10.1017/S0033291713001979
   Wolke D, 2014, PSYCHOL MED, V44, P2199, DOI 10.1017/S0033291713002912
   Wolke D, 2015, ARCH DIS CHILD, V100, P879, DOI 10.1136/archdischild-2014-306667
   Zannas AS, 2014, GENES BRAIN BEHAV, V13, P25, DOI 10.1111/gbb.12104
   Zannas AS, 2016, NEUROPSYCHOPHARMACOL, V41, P261, DOI 10.1038/npp.2015.235
NR 60
TC 7
Z9 7
U1 2
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 7
PY 2016
VL 11
IS 7
AR e0158809
DI 10.1371/journal.pone.0158809
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DR3OC
UT WOS:000379811500049
PM 27389186
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Solesvik, M
   Joa, I
   Larsen, TK
   Langeveld, J
   Johannessen, JO
   Bjornestad, J
   Anda, LG
   Gisselgard, J
   Hegelstad, WT
   Bronnick, K
AF Solesvik, Martine
   Joa, Inge
   Larsen, Tor Ketil
   Langeveld, Johannes
   Johannessen, Jan Olav
   Bjornestad, Jone
   Anda, Liss Goril
   Gisselgard, Jens
   Hegelstad, Wenche ten Velden
   Bronnick, Kolbjorn
TI Visual Hallucinations in First-Episode Psychosis: Association with
   Childhood Trauma
SO PLOS ONE
LA English
DT Article
ID NEGATIVE SYNDROME SCALE; NEURODEVELOPMENTAL MODEL; POSITIVE SYMPTOMS;
   SCHIZOPHRENIA; DELUSIONS; DISORDERS; PANSS; 1ST; INFORMATION;
   EXPERIENCES
AB Background
   Hallucinations are a core diagnostic criterion for psychotic disorders and have been investigated with regard to its association with childhood trauma in first-episode psychosis samples. Research has largely focused on auditory hallucinations, while specific investigations of visual hallucinations in first-episode psychosis remain scarce.
   Objectives
   The aims of this study were to describe the prevalence of visual hallucinations, and to explore the association between visual hallucination and childhood trauma in a first-episode psychosis sample.
   Methods
   Subjects were included from TIPS-2, a first episode psychosis study in south Rogaland, Norway. Based on the medical journal descriptions of the Positive and Negative Symptoms Scale (PANSS), a separate score for visual and auditory hallucinations was created (N = 204). Patients were grouped according to hallucination severity (none, mild, and psychotic hallucinations) and multinomial logistic regression was performed to identify factors associated with visual hallucination group.
   Results
   Visual hallucinations of a psychotic nature were reported by 26.5% of patients. The experience of childhood interpersonal trauma increased the likelihood of having psychotic visual hallucinations.
   Conclusion
   Visual hallucinations are common in first-episode psychosis, and are related to childhood interpersonal trauma.
C1 [Solesvik, Martine; Joa, Inge; Larsen, Tor Ketil; Langeveld, Johannes; Johannessen, Jan Olav; Bjornestad, Jone; Anda, Liss Goril; Gisselgard, Jens; Hegelstad, Wenche ten Velden; Bronnick, Kolbjorn] Stavanger Univ Hosp, TIPS Ctr Clin Res Psychosis, Stavanger, Rogaland, Norway.
   [Joa, Inge; Johannessen, Jan Olav; Bronnick, Kolbjorn] Univ Stavanger, Network Med Sci, Stavanger, Rogaland, Norway.
RP Bronnick, K (reprint author), Stavanger Univ Hosp, TIPS Ctr Clin Res Psychosis, Stavanger, Rogaland, Norway.; Bronnick, K (reprint author), Univ Stavanger, Network Med Sci, Stavanger, Rogaland, Norway.
EM bronnick@gmail.com
OI Hegelstad, Wenche ten Velden/0000-0003-1148-8825; Joa,
   Inge/0000-0002-5516-2336; Bronnick, Kolbjorn/0000-0002-9156-1633
FU Health Vest Trust, Norway [200202797-65]; Regional Centre for Clinical
   Research in Psychosis [911313]
FX This work was supported by the Health Vest Trust, Norway (200202797-65
   to I. J.) and the Regional Centre for Clinical Research in Psychosis (
   911313). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   American Psychiatric Association, 1987, DIAGN STAT MAN MENT
   Belsley David A., 1980, REGRESSION DIAGNOSTI
   Bendall S, 2008, SCHIZOPHRENIA BULL, V34, P568, DOI 10.1093/schbul/sbm121
   Bendall S, 2013, J NERV MENT DIS, V201, P941, DOI 10.1097/NMD.0000000000000033
   Brebion G, 2008, NEUROPSYCHOLOGY, V22, P383, DOI 10.1037/0894-4105.22.3.383
   CANNONSPOOR HE, 1982, SCHIZOPHRENIA BULL, V8, P470, DOI 10.1093/schbul/8.3.470
   Collerton D, 2005, BEHAV BRAIN SCI, V28, P737
   Compton MT, 2012, PSYCHIAT RES, V200, P702, DOI 10.1016/j.psychres.2012.07.041
   Coy AL, 2012, PSYCHIAT RES, V196, P225, DOI 10.1016/j.psychres.2011.10.017
   Dalgleish T, 2001, PSYCHOL MED, V31, P541, DOI 10.1017/S0033291701003567
   de Leede-Smith S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00367
   Dodgson G, 2009, BEHAV COGN PSYCHOTH, V37, P325, DOI 10.1017/S1352465809005244
   DRAKE RE, 1990, SCHIZOPHRENIA BULL, V16, P57, DOI 10.1093/schbul/16.1.57
   First M., 1995, STRUCTURED CLIN INTE
   Garwood L, 2015, BEHAV COGN PSYCHOTH, V43, P52, DOI 10.1017/S1352465813000714
   Goldberg Lewis R, 2006, J Trauma Dissociation, V7, P39, DOI 10.1300/J229v07n03_04
   Joa I, 2008, SCHIZOPHRENIA BULL, V34, P466, DOI 10.1093/schbul/sbm095
   KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261
   KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8
   Klaeth JR, 2009, TIDSSKRIFT NORSK PSY, P1049
   Levine SZ, 2011, PSYCHIAT RES, V188, P446, DOI 10.1016/j.psychres.2011.03.014
   Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053
   Morrison AP, 2003, BRIT J CLIN PSYCHOL, V42, P331, DOI 10.1348/014466503322528892
   Muenzenmaier KH, 2015, J TRAUMA DISSOCIATIO, V16, P442, DOI 10.1080/15299732.2015.1018475
   PERALTA V, 1994, PSYCHIAT RES, V53, P31, DOI 10.1016/0165-1781(94)90093-0
   Rajapakse T, 2011, EARLY INTERV PSYCHIA, V5, P254, DOI 10.1111/j.1751-7893.2011.00281.x
   Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x
   Read J, 2001, PSYCHIATRY, V64, P319, DOI 10.1521/psyc.64.4.319.18602
   Read J, 2004, MODELS MADNESS PSYCH
   Read J, 2014, NEUROPSYCHIATRY-LOND, V4, P65, DOI 10.2217/NPY.13.89
   Robinson DG, 1999, AM J PSYCHIAT, V156, P544
   ROSS CA, 1994, HOSP COMMUNITY PSYCH, V45, P489
   Shevlin M, 2007, J PSYCHIATR RES, V41, P222, DOI 10.1016/j.jpsychires.2006.03.004
   Shevlin M, 2011, SOC PSYCH PSYCH EPID, V46, P1203, DOI 10.1007/s00127-010-0296-x
   Stain HJ, 2014, SCHIZOPHRENIA BULL, V40, P1491, DOI 10.1093/schbul/sbt166
   Ucok A, 2007, ACTA PSYCHIAT SCAND, V116, P371, DOI 10.1111/j.1600-0447.2007.01079.x
   van Nierop M, 2014, SCHIZOPHRENIA BULL, V40, pS123, DOI 10.1093/schbul/sbt150
   van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Waters F, 2014, SCHIZOPHRENIA BULL, V40, pS233, DOI 10.1093/schbul/sbu036
   Waters F, 2014, SCHIZOPHRENIA BULL, V40, P24, DOI 10.1093/schbul/sbt167
NR 43
TC 7
Z9 7
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 4
PY 2016
VL 11
IS 5
AR e0153458
DI 10.1371/journal.pone.0153458
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DL5KR
UT WOS:000375676400017
PM 27144681
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Cristobal-Narvaez, P
   Sheinbaum, T
   Ballespi, S
   Mitjavila, M
   Myin-Germeys, I
   Kwapil, TR
   Barrantes-Vidal, N
AF Cristobal-Narvaez, Paula
   Sheinbaum, Tamara
   Ballespi, Sergi
   Mitjavila, Merce
   Myin-Germeys, Inez
   Kwapil, Thomas R.
   Barrantes-Vidal, Neus
TI Impact of Adverse Childhood Experiences on Psychotic-Like Symptoms and
   Stress Reactivity in Daily Life in Nonclinical Young Adults
SO PLOS ONE
LA English
DT Article
ID TRAUMA; SCHIZOTYPY; MECHANISMS; SCHIZOPHRENIA; METAANALYSIS;
   ASSOCIATION; NEGLECT; ABUSE; RISK; PSYCHOPATHOLOGY
AB Background
   There is increasing interest in elucidating the association of different childhood adversities with psychosis-spectrum symptoms as well as the mechanistic processes involved. This study used experience sampling methodology to examine (i) associations of a range of childhood adversities with psychosis symptom domains in daily life; (ii) whether associations of abuse and neglect with symptoms are consistent across self-report and interview methods of trauma assessment; and (iii) the role of different adversities in moderating affective, psychotic-like, and paranoid reactivity to situational and social stressors.
   Method
   A total of 206 nonclinical young adults were administered self-report and interview measures to assess childhood abuse, neglect, bullying, losses, and general traumatic events. Participants received personal digital assistants that signaled them randomly eight times daily for one week to complete questionnaires about current experiences, including symptoms, affect, and stress.
   Results
   Self-reported and interview-based abuse and neglect were associated with psychotic-like and paranoid symptoms, whereas only self-reported neglect was associated with negative-like symptoms. Bullying was associated with psychotic-like symptoms. Losses and general traumatic events were not directly associated with any of the symptom domains. All the childhood adversities were associated with stress reactivity in daily life. Interpersonal adversities (abuse, neglect, bullying, and losses) moderated psychotic-like and/or paranoid reactivity to situational and social stressors, whereas general traumatic events moderated psychotic-like reactivity to situational stress. Also, different interpersonal adversities exacerbated psychotic-like and/or paranoid symptoms in response to distinct social stressors.
   Discussion
   The present study provides a unique examination of how childhood adversities impact the expression of spectrum symptoms in the real world and lends support to the notion that stress reactivity is a mechanism implicated in the experience of reality distortion in individuals exposed to childhood trauma. Investigating the interplay between childhood experience and current context is relevant for uncovering potential pathways to the extended psychosis phenotype.
C1 [Cristobal-Narvaez, Paula; Sheinbaum, Tamara; Ballespi, Sergi; Mitjavila, Merce; Barrantes-Vidal, Neus] Univ Autonoma Barcelona, Dept Psicol Clin & Salut, E-08193 Barcelona, Spain.
   [Myin-Germeys, Inez] Katholieke Univ Leuven, Dept Neurosci, Ctr Contextual Psychiat, Leuven, Belgium.
   [Kwapil, Thomas R.; Barrantes-Vidal, Neus] Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA.
   [Barrantes-Vidal, Neus] St Pere Claver Fundacio Sanitaria, Barcelona, Spain.
   [Barrantes-Vidal, Neus] Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain.
RP Barrantes-Vidal, N (reprint author), Univ Autonoma Barcelona, Dept Psicol Clin & Salut, E-08193 Barcelona, Spain.; Barrantes-Vidal, N (reprint author), Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA.; Barrantes-Vidal, N (reprint author), St Pere Claver Fundacio Sanitaria, Barcelona, Spain.; Barrantes-Vidal, N (reprint author), Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain.
EM neus.barrantes@uab.cat
RI Myin-Germeys, Inez/L-5106-2014; Sheinbaum, Tamara/A-8008-2016;
   Barrantes-Vidal, Neus/A-9578-2013; Cristobal-Narvaez, Paula/K-3265-2017;
   Mitjavila, Merce/L-3760-2014; Ballespi, Sergi/L-6492-2014; Kwapil,
   Thomas/I-3163-2019; Kwapil, Thomas R./L-1127-2014
OI Sheinbaum, Tamara/0000-0002-2268-7697; Barrantes-Vidal,
   Neus/0000-0002-8671-1238; Cristobal-Narvaez, Paula/0000-0001-8184-6347;
   Mitjavila, Merce/0000-0003-2390-3774; Ballespi,
   Sergi/0000-0002-6584-4138; Kwapil, Thomas R./0000-0003-1116-5954
FU Spanish Ministerio de Economia y Competitividad (Plan Nacional de I+D)
   [PSI2011-30321-C02-01, PSI2014-54009-R]; Red de Excelencia PROMOSAM
   [PSI2014-56303-REDT]; Fundacio La Marato de TV3 [091110]; Generalitat de
   Catalunya (Suport als Grups de Recerca) [2014SGR1070]; Institucio
   Catalana de Recerca i Estudis Avancats (ICREA), ICREA Academia Award
FX This work was supported by the Spanish Ministerio de Economia y
   Competitividad (Plan Nacional de I+D PSI2011-30321-C02-01 &
   PSI2014-54009-R and Red de Excelencia PROMOSAM PSI2014-56303-REDT),
   Fundacio La Marato de TV3 (091110), and Generalitat de Catalunya (Suport
   als Grups de Recerca 2014SGR1070). NBV is supported by the Institucio
   Catalana de Recerca i Estudis Avancats (ICREA), ICREA Academia Award.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Arntz A., 2010, INTERVIEW TRAUMATIC
   Arseneault L, 2011, AM J PSYCHIAT, V168, P65, DOI 10.1176/appi.ajp.2010.10040567
   Ashford CD, 2012, J EXP PSYCHOPATHOL, V3, P624, DOI 10.5127/jep.020611
   Barrantes-Vidal N, 2015, SCHIZOPHRENIA BULL, V41, pS408, DOI 10.1093/schbul/sbu191
   Barrantes-Vidal N, 2013, J ABNORM PSYCHOL, V122, P1077, DOI 10.1037/a0034793
   Beards S, 2014, SOC PSYCH PSYCH EPID, V49, P1541, DOI 10.1007/s00127-014-0953-6
   Bentall RP, 2008, SCHIZOPHRENIA BULL, V34, P1012, DOI 10.1093/schbul/sbn103
   Bentall RP, 2014, SOC PSYCH PSYCH EPID, V49, P1011, DOI 10.1007/s00127-014-0914-0
   Bentall RP, 2012, SCHIZOPHRENIA BULL, V38, P734, DOI 10.1093/schbul/sbs049
   Bernstein D, 1998, CHILDHOOD TRAUMA QUE
   BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x
   Bifulco A., 2013, UNDERSTANDING ADULT
   Bowlby J., 1973, ATTACHMENT LOSS, V2
   Bremner JD, 2000, DEPRESS ANXIETY, V12, P1, DOI 10.1002/1520-6394(2000)12:1<1::AID-DA1>3.0.CO;2-W
   Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003
   Chun CA, 2017, PERSONAL DISORD, V8, P64, DOI 10.1037/per0000141
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037//0033-2909.112.1.155
   Conner TS, 2009, SOC PERSONAL PSYCHOL, V3, P292, DOI 10.1111/j.1751-9004.2009.00170.x
   Debbane M, 2015, SCHIZOPHRENIA BULL, V41, pS386, DOI 10.1093/schbul/sbu175
   deVries M. W., 1992, EXPERIENCE PSYCHOPAT
   Dohrenwend BP, 2006, PSYCHOL BULL, V132, P477, DOI 10.1037/0033-2909.132.3.477
   Ettinger U, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00018
   Fisher H, 2008, SOCIETY AND PSYCHOSIS, P95, DOI 10.1017/CBO9780511544064.007
   Fisher HL, 2015, DEV PSYCHOPATHOL, V27, P1399, DOI 10.1017/S0954579415000838
   Fisher HL, 2012, PSYCHIAT RES, V196, P323, DOI 10.1016/j.psychres.2011.12.004
   Galletly C, 2011, SCHIZOPHR RES, V127, P76, DOI 10.1016/j.schres.2010.12.010
   Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551
   Glaser JP, 2006, J PSYCHOSOM RES, V61, P229, DOI 10.1016/j.jpsychores.2006.04.014
   Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605
   Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531
   Hektner J. M., 2007, EXPERIENCE SAMPLING
   Hildyard KL, 2002, CHILD ABUSE NEGLECT, V26, P679, DOI 10.1016/S0145-2134(02)00341-1
   Kwapil TR, 2012, PSYCHOL MED, V42, P2555, DOI 10.1017/S0033291712000827
   Kwapil TR, 2015, SCHIZOPHRENIA BULL, V41, pS366, DOI 10.1093/schbul/sbu186
   Lardinois M, 2011, ACTA PSYCHIAT SCAND, V123, P28, DOI 10.1111/j.1600-0447.2010.01594.x
   Lataster T, 2013, PSYCHOL MED, V43, P1389, DOI 10.1017/S0033291712002279
   Lobbestael J, 2009, CHILD ABUSE NEGLECT, V33, P505, DOI 10.1016/j.chiabu.2009.03.002
   Longden E, 2016, EPIDEMIOL PSYCH SCI, V25, P349, DOI 10.1017/S204579601500044X
   March D, 2008, EPIDEMIOL REV, V30, P84, DOI 10.1093/epirev/mxn006
   Matheson SL, 2013, PSYCHOL MED, V43, P225, DOI 10.1017/S0033291712000785
   McCabe KL, 2012, J PSYCHIATR RES, V46, P600, DOI 10.1016/j.jpsychires.2012.01.023
   Mikulincer M., 2007, ATTACHMENT ADULTHOOD
   Monroe SM, 2008, ANNU REV CLIN PSYCHO, V4, P33, DOI 10.1146/annurev.clinpsy.4.022007.141207
   Muthen L, 1998, MPLUS USERS GUIDE
   Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005
   Nezlek J. B, 2011, MULTILEVEL MODELING
   Oorschot M, 2009, PSYCHOL ASSESSMENT, V21, P498, DOI 10.1037/a0017077
   Petersen AC, 2014, NEW DIRECTIONS IN CHILD ABUSE AND NEGLECT RESEARCH, P31
   Ruby Eugene, 2014, Front Psychol Behav Sci, V3, P1
   Schimmenti A, 2015, PSYCHIAT INVEST, V12, P415, DOI 10.4306/pi.2015.12.3.415
   Sheinbaum T., 2015, SCHIZOTYPY NEW DIMEN, P116
   Sheinbaum T, 2014, PSYCHIAT RES, V220, P691, DOI 10.1016/j.psychres.2014.07.030
   Simpson J. A., 2012, OXFORD HDB PERSONALI, P493
   Spence R, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4085
   Thompson JL, 2009, SCHIZOPHR RES, V108, P176, DOI 10.1016/j.schres.2008.12.005
   van Dam DS, 2015, PSYCHOL MED, V45, P1363, DOI 10.1017/S0033291714001561
   van Dam DS, 2012, PSYCHOL MED, V42, P2463, DOI 10.1017/S0033291712000360
   van Nierop M, 2014, SCHIZOPHRENIA BULL, V40, pS123, DOI 10.1093/schbul/sbt150
   van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814
   van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563
   van Winkel R, 2008, SCHIZOPHRENIA BULL, V34, P1095, DOI 10.1093/schbul/sbn101
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Velikonja T, 2015, PSYCHOL MED, V45, P947, DOI 10.1017/S0033291714002086
   Wichers M, 2009, PSYCHOL MED, V39, P1077, DOI 10.1017/S0033291708004388
NR 64
TC 18
Z9 18
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 15
PY 2016
VL 11
IS 4
AR e0153557
DI 10.1371/journal.pone.0153557
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ6AH
UT WOS:000374291800030
PM 27082442
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Kasanova, Z
   Hernaus, D
   Vaessen, T
   Van Amelsvoort, T
   Winz, O
   Heinzel, A
   Pruessner, J
   Mottaghy, FM
   Collip, D
   Myin-Germeys, I
AF Kasanova, Zuzana
   Hernaus, Dennis
   Vaessen, Thomas
   Van Amelsvoort, Therese
   Winz, Oliver
   Heinzel, Alexander
   Pruessner, Jens
   Mottaghy, Felix M.
   Collip, Dina
   Myin-Germeys, Inez
TI Early-Life Stress Affects Stress-Related Prefrontal Dopamine Activity in
   Healthy Adults, but Not in Individuals with Psychotic Disorder
SO PLOS ONE
LA English
DT Article
ID GLUCOCORTICOID-RECEPTOR GENE; POSITRON-EMISSION-TOMOGRAPHY; ABUSE
   QUESTIONNAIRE CECA.Q; CHILDHOOD TRAUMA; RELEASE; SCHIZOPHRENIA; CORTEX;
   RISK; STRIATUM; EXPERIENCE
AB Early life stress may have a lasting impact on the developmental programming of the dopamine (DA) system implicated in psychosis. Early adversity could promote resilience by calibrating the prefrontal stress-regulatory dopaminergic neurotransmission to improve the individual's fit with the predicted stressful environment. Aberrant reactivity to such match between proximal and distal environments may, however, enhance psychosis disease risk. We explored the combined effects of childhood adversity and adult stress by exposing 12 unmedicated individuals with a diagnosis of non-affective psychotic disorder (NAPD) and 12 healthy controls (HC) to psychosocial stress during an [F-18]fallypride positron emission tomography. Childhood trauma divided into early (ages 0-11 years) and late (12-18 years) was assessed retrospectively using a questionnaire. A significant group x childhood trauma interaction on the spatial extent of stress-related [18F] fallypride displacement was observed in the mPFC for early (b=-8.45, t(1,23) = -3.35, p=.004) and late childhood trauma (b=7.86, t(1,23) = -2.48, p=.023). In healthy individuals, the spatial extent of mPFC DA activity under acute psychosocial stress was positively associated with the severity of early (b=7.23, t(11) = 3.06, p=.016) as well as late childhood trauma (b=-7.86, t(1,23) = -2.48, p=.023). Additionally, a trend-level main effect of early childhood trauma on subjective stress response emerged within this group (b=-.7, t(11) = -2, p=.07), where higher early trauma correlated with lower subjective stress response to the task. In the NAPD group, childhood trauma was not associated with the spatial extent of the tracer displacement in mPFC (b=-1.22, t(11) = -0.67), nor was there a main effect of trauma on the subjective perception of stress within this group (b=.004, t(11) = .01, p=.99). These findings reveal a potential mechanism of neuroadaptation of prefrontal DA transmission to early life stress and suggest its role in resilience and vulnerability to psychosis.
C1 [Kasanova, Zuzana; Vaessen, Thomas; Van Amelsvoort, Therese; Myin-Germeys, Inez] KU Leuven Univ Leuven, Dept Neurosci, Leuven, Belgium.
   [Hernaus, Dennis; Collip, Dina] Maastricht Univ, Sch Mental Hlth & NeuroSci MHeNS, South Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Psychol,EURON, NL-6200 MD Maastricht, Netherlands.
   [Van Amelsvoort, Therese] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands.
   [Winz, Oliver; Heinzel, Alexander; Mottaghy, Felix M.] Univ Hosp RWTH Aachen Univ, Dept Nucl Med, Aachen, Germany.
   [Pruessner, Jens] McGill Univ, Dept Psychiat, Douglas Mental Hlth Inst, Montreal, PQ, Canada.
   [Mottaghy, Felix M.] Maastricht Univ Hosp, Dept Nucl Med, Maastricht, Netherlands.
RP Kasanova, Z (reprint author), KU Leuven Univ Leuven, Dept Neurosci, Leuven, Belgium.
EM zuzana.kasanova@kuleuven.be
RI Myin-Germeys, Inez/L-5106-2014; Heinzel, Alexander/G-7725-2017
OI Heinzel, Alexander/0000-0002-2430-4557; Kasanova,
   Zuzana/0000-0002-8795-5373
FU ERC [309767 - INTERACT]; Maastricht University; Network of European
   Neuroscience Schools
FX This study was supported by an ERC consolidator grant to Inez
   Myin-Germeys (ERC-2012-StG, project 309767 - INTERACT). Dina Collip and
   Zuzana Kasanova were supported by a Maastricht University post-doc and
   pre-doc Kootstra fellowship, respectively. Dennis Hernaus was funded by
   the Network of European Neuroscience Schools. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x
   Alpert NM, 2003, NEUROIMAGE, V19, P1049, DOI 10.1016/S1053-8119(03)00186-1
   Badgaiyan RD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00125
   Bet PM, 2009, AM J MED GENET B, V150B, P660, DOI 10.1002/ajmg.b.30886
   Bifulco A, 2005, BRIT J CLIN PSYCHOL, V44, P563, DOI 10.1348/014466505X35344
   Boksa P, 2003, NEUROSCI BIOBEHAV R, V27, P91, DOI 10.1016/S0149-7634(03)00012-5
   Butts KA, 2011, P NATL ACAD SCI USA, V108, P18459, DOI 10.1073/pnas.1111746108
   Cansino S, 2009, INT J PSYCHOPHYSIOL, V71, P64, DOI 10.1016/j.ijpsycho.2008.07.005
   Ceccarini J, 2012, J NUCL MED, V53, P1565, DOI 10.2967/jnumed.111.099416
   Christian BT, 2006, NEUROIMAGE, V31, P139, DOI 10.1016/j.neuroimage.2005.11.052
   Collip D, 2011, PSYCHOL MED, V41, P2305, DOI 10.1017/S0033291711000602
   Collip D, 2011, CNS NEUROSCI THER, V17, P612, DOI 10.1111/j.1755-5949.2010.00213.x
   Daskalakis NP, 2013, PSYCHONEUROENDOCRINO, V38, P1858, DOI 10.1016/j.psyneuen.2013.06.008
   Eacott MJ, 1999, MEMORY, V7, P279, DOI 10.1080/096582199387922
   Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102
   Green MJ, 2014, J PSYCHIATR RES, V49, P43, DOI 10.1016/j.jpsychires.2013.10.018
   Grunder G, 2003, J NUCL MED, V44, P109
   Hermans EJ, 2014, TRENDS NEUROSCI, V37, P304, DOI 10.1016/j.tins.2014.03.006
   Hernaus D., 2015, TRANSLATIONAL PSYCHI
   Hernaus D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065662
   Holtzman CW, 2013, NEUROSCIENCE, V249, P172, DOI 10.1016/j.neuroscience.2012.12.017
   Horga G, 2014, JAMA PSYCHIAT, V71, P489, DOI 10.1001/jamapsychiatry.2014.191
   Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169
   Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493
   Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x
   Kaenmaki M, 2010, J NEUROCHEM, V114, P1745, DOI 10.1111/j.1471-4159.2010.06889.x
   KEEFE KA, 1990, BRAIN RES, V527, P350, DOI 10.1016/0006-8993(90)91158-D
   Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10
   Kelleher I, 2013, AM J PSYCHIAT, V170, P734, DOI 10.1176/appi.ajp.2012.12091169
   Latagliata EC, 2014, PSYCHOPHARMACOLOGY, V231, P4099, DOI 10.1007/s00213-014-3549-7
   Lataster J, 2014, SCHIZOPHRENIA BULL, V40, P66, DOI 10.1093/schbul/sbs187
   Lataster J, 2011, NEUROIMAGE, V58, P1081, DOI 10.1016/j.neuroimage.2011.07.030
   Matheson SL, 2013, PSYCHOL MED, V43, P225, DOI 10.1017/S0033291712000785
   McLaughlin KA, 2013, J AM ACAD CHILD PSY, V52, P815, DOI 10.1016/j.jaac.2013.05.011
   Mizrahi R, 2012, BIOL PSYCHIAT, V71, P561, DOI 10.1016/j.biopsych.2011.10.009
   Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005
   Nagano-Saito A, 2013, SYNAPSE, V67, P821, DOI 10.1002/syn.21700
   Nederhof E, 2012, PHYSIOL BEHAV, V106, P691, DOI 10.1016/j.physbeh.2011.12.008
   Pani L, 2000, MOL PSYCHIATR, V5, P14, DOI 10.1038/sj.mp.4000589
   Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004
   Ramsay H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079741
   Read J, 2001, PSYCHIATRY, V64, P319, DOI 10.1521/psyc.64.4.319.18602
   Roy CA, 2004, J NERV MENT DIS, V192, P343, DOI 10.1097/01.nmd.0000126701.23121.fa
   Scornaiencki R, 2009, INT J NEUROPSYCHOPH, V12, P1195, DOI 10.1017/S1461145709000121
   Smith N, 2002, SOC PSYCH PSYCH EPID, V37, P572, DOI 10.1007/s00127-002-0589-9
   Soliman A, 2008, NEUROPSYCHOPHARMACOL, V33, P2033, DOI 10.1038/sj.npp.1301597
   SUDHA S, 1995, PHYSIOL BEHAV, V57, P1061, DOI 10.1016/0031-9384(94)00369-G
   van Os J, 2006, ACTA PSYCHIAT SCAND, V113, P91, DOI 10.1111/j.1600-0447.2005.00659.x
   van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Ventura R, 2013, CEREB CORTEX, V23, P1606, DOI 10.1093/cercor/bhs145
   Walker EF, 1997, PSYCHOL REV, V104, P667, DOI 10.1037/0033-295X.104.4.667
   Walker EF, 2013, DEV PSYCHOPATHOL, V25, P1585, DOI 10.1017/S0954579413000783
   Watt MJ, 2014, PSYCHOPHARMACOLOGY, V231, P1627, DOI 10.1007/s00213-013-3353-9
NR 54
TC 5
Z9 5
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 23
PY 2016
VL 11
IS 3
AR e0150746
DI 10.1371/journal.pone.0150746
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH3QJ
UT WOS:000372701200030
PM 27007554
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU van Winkel, R
AF van Winkel, Ruud
CA GROUP Investigators
TI Further Evidence That Cannabis Moderates Familial Correlation of
   Psychosis-Related Experiences
SO PLOS ONE
LA English
DT Article
ID STRUCTURED INTERVIEW; ENVIRONMENT; INSTRUMENT; RISK; SCHIZOPHRENIA;
   RELIABILITY; LIABILITY; SYMPTOMS
AB Background Familial correlations underlie heritability estimates of psychosis. If gene-environment interactions are important, familial correlation will vary as a function of environmental exposure.
   Methods Associations between sibling and parental schizotypy (n = 669 pairs, n = 1222 observations), and between sibling schizotypy and patient CAPE psychosis (n = 978 pairs, n = 1723 observations) were examined as a function of sibling cannabis use. This design is based on the prediction that in unaffected siblings who are not exposed, vulnerability for psychosis will remain latent, whereas in case of exposure, latent psychosis vulnerability may become expressed, at the level of schizotypal symptoms, causing the phenotypic correlation between relatives to become "visible" under the influence of cannabis.
   Results Siblings exposed to recent cannabis use resembled their patient-relative more closely in terms of positive schizotypy (urinalysis(+): B = 0.30, P<.001; urinalysis(-): B = 0.10, p<0.001; p-interaction = 0.0135). Similarly, the familial correlation in positive schizotypy between parent and sibling was significantly greater in siblings recently exposed to cannabis (urinalysis (+): B = 0.78, P<.001; urinalysis(-): B = 0.43, p<0.001; p interaction = 0.0017). Results were comparable when using lifetime cannabis frequency of use as exposure instead of recent use. Parental schizotypy did not predict cannabis use in the healthy sibling, nor in the patient. Similarly, parental cannabis use was not associated with level of schizotypy in the sibling, nor with psychotic symptoms in the patient, making gene-environment correlation unlikely.
   Conclusion Familial correlation of psychosis-related experiences varies considerably as a function of exposure to cannabis, confirming the importance of gene-cannabis interaction in shifts of expression of psychosis-related experiences.
C1 [van Winkel, Ruud] Univ Psychiat Ctr KU, Leuven, Belgium.
   [van Winkel, Ruud] Maastricht Univ, Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, Maastricht, Netherlands.
RP van Winkel, R (reprint author), Univ Psychiat Ctr KU, Leuven, Belgium.
EM ruud.vanwinkel@upckuleuven.be
RI Myin-Germeys, Inez/L-5106-2014
OI Bruggeman, Richard/0000-0002-3238-8471
FU Geestkracht program of Dutch Health Research Council (ZON-MW)
   [10-000-1002]; Site Amsterdam: Academic Psychiatric Centre AMC; Site
   Amsterdam: Academic Psychiatric Centre Ingeest; Site Amsterdam: Academic
   Psychiatric Centre Arkin; Site Amsterdam: Academic Psychiatric Centre
   Dijk en Duin; Site Amsterdam: Academic Psychiatric Centre Rivierduinen;
   Site Amsterdam: Academic Psychiatric Centre Erasmus MC; Site Amsterdam:
   Academic Psychiatric Centre GGZ Noord Holland Noord; Site Utrecht:
   University Medical Centre Utrecht; Site Amsterdam: Academic Psychiatric
   Centre Altrecht; Site Amsterdam: Academic Psychiatric Centre Symfora;
   Site Amsterdam: Academic Psychiatric Centre Meerkanten; Site Amsterdam:
   Academic Psychiatric Centre Riagg Amersfoort; Site Groningen: University
   Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Dimence;
   Mediant; GGZ De Grote Rivieren and Parnassia psycho-medical centre; Site
   Maastricht: Maastricht University Medical Center; GGZ Eindhoven; GGZ
   Midden-Brabant; GGZ Oost-Brabant; GGZ NoordMidden Limburg; Mondriaan
   Zorggroep; Prins Clauscentrum Sittard; RIAGG Roermond; Universitair
   Centrum Sint-Jozef Kortenberg; CAPRI University of Antwerp; PC Ziekeren
   Sint-Truiden; PZ Sancta Maria Sint-Truiden; GGZ Overpelt; OPZ Rekem;
   Jansen-Cilag; Eli Lilly and Company; Astra- Zeneca and Lundbeck;
   European Community's Seventh Framework Program (Project EU-GEI)
   [HEALTH-F2-2009-241909]; Site Amsterdam: Academic Psychiatric Centre
   Delta
FX The infrastructure for the GROUP study is funded by the Geestkracht
   program of the Dutch Health Research Council (ZON-MW, grant number
   10-000-1002) and matching funds from participating unversities and
   mental health care organizations (Site Amsterdam: Academic Psychiatric
   Centre AMC, Ingeest, Arkin, Dijk en Duin, Rivierduinen, Erasmus MC, GGZ
   Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht,
   Altrecht, Symfora, Meerkanten, Riagg Amersfoort, Delta; Site Groningen:
   University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe,
   Dimence, Mediant, GGZ De Grote Rivieren and Parnassia psycho-medical
   centre; Site Maastricht: Maastricht University Medical Center, GGZ
   Eindhoven, GGZ Midden-Brabant, GGZ Oost-Brabant, GGZ NoordMidden
   Limburg, Mondriaan Zorggroep, Prins Clauscentrum Sittard, RIAGG
   Roermond, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University
   of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ
   Overpelt, OPZ Rekem). The analyses were supported by unrestricted grants
   from Jansen-Cilag, Eli Lilly and Company, Astra- Zeneca and Lundbeck.
   The research leading to these results has received funding from the
   European Community's Seventh Framework Program under grant agreement No.
   HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615
   Association AP, 2000, DIAGN STAT MAN MENT
   Bromet EJ, 2011, AM J PSYCHIAT
   Demjaha A, 2012, SCHIZOPHRENIA BULL, V38, P209, DOI 10.1093/schbul/sbr100
   Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313
   Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873
   Hanssen M, 2006, J ABNORM PSYCHOL, V115, P5, DOI 10.1037/0021-843X.115.1.5
   Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531
   Kahn RS, 2011, ARCH GEN PSYCHIAT, V68, P138, DOI 10.1001/archgenpsychiatry.2010.132
   Kelleher I, 2011, PSYCHOL MED, V41, P1, DOI 10.1017/S0033291710001005
   KENDLER KS, 1986, AM J PSYCHIAT, V143, P279
   KENDLER KS, 1989, SCHIZOPHRENIA BULL, V15, P559, DOI 10.1093/schbul/15.4.559
   Khoury MJ, 1993, GENETIC EPIDEMIOLOGY
   Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x
   Liraud F, 2004, J NERV MENT DIS, V192, P352, DOI 10.1097/01.nmd.00126702.30745.1d
   Matheson SL, 2011, SCHIZOPHR RES, V133, P133, DOI 10.1016/j.schres.2011.09.020
   Musshoff F, 2006, THER DRUG MONIT, V28, P155, DOI 10.1097/01.ftd.0000197091.07807.22
   NIMH, 1992, GEN IN FAM INT GEN S
   O'Tuathaigh CMP, 2010, NEUROPSYCHOPHARMACOL, V35, P2262, DOI 10.1038/npp.2010.100
   StataCorp, 2011, STAT STAT SOFTW REL
   Tryon RC, 1940, YEARBOOK NATIONAL SO, V39, P111
   van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563
   van Winkel R, 2014, ANNU REV CLIN PSYCHO, V10, P767, DOI 10.1146/annurev-clinpsy-032813-153631
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482
   Wang YT, 2006, CANCER EPIDEM BIOMAR, V15, P124, DOI 10.1158/1055-9965.EPI-05-0304
   WHO, 1990, COMP INT DIAGN INT C
   WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978
   Wing J. K., 1974, MEASUREMENT CLASSIFI
   WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589
NR 30
TC 8
Z9 8
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 18
PY 2015
VL 10
IS 9
AR e0137625
DI 10.1371/journal.pone.0137625
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS0ZE
UT WOS:000361790200028
PM 26384217
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Liu, JJ
   Lou, FL
   Lavebratt, C
   Forsell, Y
AF Liu, Jia Jia
   Lou, Fenglan
   Lavebratt, Catharina
   Forsell, Yvonne
TI Impact of Childhood Adversity and Vasopressin receptor 1a Variation on
   Social Interaction in Adulthood: A Cross-Sectional Study
SO PLOS ONE
LA English
DT Article
ID POSTTRAUMATIC-STRESS-DISORDER; ARGININE-VASOPRESSIN; INTERVIEW SCHEDULE;
   PROMOTER REGION; BEHAVIOR; ASSOCIATION; PSYCHOSIS; GENE; MICROSATELLITE;
   POLYMORPHISMS
AB Background
   Arginine vasopressin (AVP) plays a role in social behavior, through receptor AVPR1A. The promoter polymorphism AVPR1A RS3 has been associated with human social behaviors, and with acute response to stress. Here, the relationships between AVPR1A RS3, early-life stressors, and social interaction in adulthood were explored.
   Methods
   Adult individuals from a Swedish population-based cohort (n = 1871) were assessed for self-reported availability of social integration and social attachment and for experience of childhood adversities. Their DNA samples were genotyped for the microsatellite AVPR1A RS3.
   Results
   Among males, particularly those homozygous for the long alleles of AVPR1A RS3 were vulnerable to childhood adversity for their social attachment in adulthood. A similar vulnerability to childhood adversity among long allele carriers was found on adulthood social integration, but here both males and females were influenced.
   Limitation
   Data were self-reported and childhood adversity data were retrospective.
   Conclusions
   Early-life stress influenced the relationship between AVPR1A genetic variants and social interaction. For social attachment, AVPR1A was of importance in males only. The findings add to previous reports on higher acute vulnerability to stress in persons with long AVPR1A RS3 alleles and increased AVP levels.
C1 [Liu, Jia Jia; Lou, Fenglan] Shandong Univ, Sch Nursing, Jinan 250012, Peoples R China.
   [Liu, Jia Jia; Lavebratt, Catharina] Karolinska Inst, Neurogenet Unit, Dept Mol Med & Surg, Stockholm, Sweden.
   [Lavebratt, Catharina] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden.
   [Forsell, Yvonne] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
RP Lavebratt, C (reprint author), Karolinska Inst, Neurogenet Unit, Dept Mol Med & Surg, Stockholm, Sweden.
EM catharina.lavebratt@ki.se
FU Swedish Research Council [2009-5546, 20103631]; China Scholarship
   Council; Karolinska Institutet's Faculty Funds; Stockholm County Council
   [SLL20110560, 20090281]; Karolinska Institutet [SLL20110560, 20090281]
FX This work was supported by the Swedish Research Council (www.vr.se;
   2009-5546 YF, 20103631 CL), the China Scholarship Council
   (www.csc.edu.cn), the Karolinska Institutet's Faculty Funds
   (https://fonder.ki.se), and the regional agreement on medical training
   and clinical research between Stockholm County Council and Karolinska
   Institutet (www.forskningsstod.sll.se; SLL20110560 CL, 20090281 YF). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6
   Amaral DG, 2003, ANN NY ACAD SCI, V1000, P337, DOI 10.1196/annanls.1280.015
   Avinun R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025274
   Bachner-Melman R, 2005, J INDIVID DIFFER, V26, P2, DOI DOI 10.1027/1614-0001.26.1.2
   Bentall RP, 2014, SOC PSYCH PSYCH EPID, V49, P1011, DOI 10.1007/s00127-014-0914-0
   Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924
   Carrion VG, 2001, BIOL PSYCHIAT, V50, P943, DOI 10.1016/S0006-3223(01)01218-5
   Dvir Y, 2013, CHILD ADOL PSYCH CL, V22, P629, DOI 10.1016/j.chc.2013.04.006
   Eklund M, 2007, NORD J PSYCHIAT, V61, P182, DOI 10.1080/08039480701352439
   Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229
   Ford E, 2011, J AFFECT DISORDERS, V133, P320, DOI 10.1016/j.jad.2011.03.017
   Halonen JI, 2014, J EPIDEMIOL COMMUN H, V68, P741, DOI 10.1136/jech-2013-203441
   Hammock EAD, 2005, GENES BRAIN BEHAV, V4, P289, DOI 10.1111/j.1601-183X.2005.00119.x
   Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427
   Hammock EAD, 2002, EUR J NEUROSCI, V16, P399, DOI 10.1046/j.1460-9568.2002.02083.x
   Hammock EAD, 2007, ADV GENET, V59, P107, DOI 10.1016/S0065-2660(07)59004-8
   HENDERSON S, 1980, PSYCHOL MED, V10, P723, DOI 10.1017/S003329170005501X
   Humphreys K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022547
   Insel TR, 2000, CURR OPIN NEUROBIOL, V10, P784, DOI 10.1016/S0959-4388(00)00146-X
   Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189
   Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125
   Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x
   Kreek MJ, 2011, BIOL PSYCHIAT, V70, P502, DOI 10.1016/j.biopsych.2011.07.013
   Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x
   Levin R, 2009, PSYCHONEUROENDOCRINO, V34, P901, DOI 10.1016/j.psyneuen.2008.12.014
   Lundberg I, 2005, SOC PSYCH PSYCH EPID, V40, P475, DOI 10.1007/s00127-005-0911-4
   Melas PA, 2010, J MED ETHICS, V36, P93, DOI 10.1136/jme.2009.032367
   Meyer-Lindenberg A, 2009, MOL PSYCHIATR, V14, P968, DOI 10.1038/mp.2008.54
   Orwelius L, 2011, INTENS CARE MED, V37, P831, DOI 10.1007/s00134-011-2137-0
   Schacter DL, 1996, CURR OPIN NEUROBIOL, V6, P207, DOI 10.1016/S0959-4388(96)80074-2
   Sjoholm LK, 2009, J AFFECT DISORDERS, V118, P124, DOI 10.1016/j.jad.2009.02.009
   Storm EE, 2005, NEURON, V47, P483, DOI 10.1016/j.neuron.2005.08.004
   Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109
   Thompson R, 2004, PSYCHONEUROENDOCRINO, V29, P35, DOI 10.1016/S0306-4530(02)00133-6
   Thompson RR, 2006, P NATL ACAD SCI USA, V103, P7889, DOI 10.1073/pnas.0600406103
   UNDEN AL, 1989, SOC SCI MED, V29, P1387, DOI 10.1016/0277-9536(89)90240-2
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105
   Yirmiya N, 2006, MOL PSYCHIATR, V11, P488, DOI 10.1038/sj.mp.4001812
NR 39
TC 9
Z9 9
U1 2
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 21
PY 2015
VL 10
IS 8
AR e0136436
DI 10.1371/journal.pone.0136436
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CP5MR
UT WOS:000359926900111
PM 26295806
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Sheinbaum, T
   Bifulco, A
   Ballespi, S
   Mitjavila, M
   Kwapil, TR
   Barrantes-Vidal, N
AF Sheinbaum, Tamara
   Bifulco, Antonia
   Ballespi, Sergi
   Mitjavila, Merce
   Kwapil, Thomas R.
   Barrantes-Vidal, Neus
TI Interview Investigation of Insecure Attachment Styles as Mediators
   between Poor Childhood Care and Schizophrenia-Spectrum Phenomenology
SO PLOS ONE
LA English
DT Editorial Material
ID ADULT ATTACHMENT; PSYCHOSIS LINKING; ROLE REVERSAL; SELF-ESTEEM;
   SCHIZOTYPY; DEPRESSION; SYMPTOMS; TRAUMA; ADVERSITIES; SAMPLE
AB Background
   Insecure attachment styles have received theoretical attention and some initial empirical support as mediators between childhood adverse experiences and psychotic phenomena; however, further specificity needs investigating. The present interview study aimed to examine (i) whether two forms of poor childhood care, namely parental antipathy and role reversal, were associated with subclinical positive and negative symptoms and schizophrenia-spectrum personality disorder (PD) traits, and (ii) whether such associations were mediated by specific insecure attachment styles.
   Method
   A total of 214 nonclinical young adults were interviewed for subclinical symptoms (Comprehensive Assessment of At-Risk Mental States), schizophrenia-spectrum PDs (Structured Clinical Interview for DSM-IV Axis II Disorders), poor childhood care (Childhood Experience of Care and Abuse Interview), and attachment style (Attachment Style Interview). Participants also completed the Beck Depression Inventory-II and all the analyses were conducted partialling out the effects of depressive symptoms.
   Results
   Both parental antipathy and role reversal were associated with subclinical positive symptoms and with paranoid and schizotypal PD traits. Role reversal was also associated with subclinical negative symptoms. Angry-dismissive attachment mediated associations between antipathy and subclinical positive symptoms and both angry-dismissive and enmeshed attachment mediated associations of antipathy with paranoid and schizotypal PD traits. Enmeshed attachment mediated associations of role reversal with paranoid and schizotypal PD traits.
   Conclusions
   Attachment theory can inform lifespan models of how adverse developmental environments may increase the risk for psychosis. Insecure attachment provides a promising mechanism for understanding the development of schizophrenia-spectrum phenomenology and may offer a useful target for prophylactic intervention.
C1 [Sheinbaum, Tamara; Ballespi, Sergi; Mitjavila, Merce; Barrantes-Vidal, Neus] Univ Autonoma Barcelona, Dept Psicol Clin & Salut, E-08193 Barcelona, Spain.
   [Bifulco, Antonia] Middlesex Univ, Dept Psychol, London N17 8HR, England.
   [Kwapil, Thomas R.; Barrantes-Vidal, Neus] Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA.
   [Barrantes-Vidal, Neus] Sant Pere Claver Fdn Sanitaria, Barcelona, Spain.
   [Barrantes-Vidal, Neus] Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain.
RP Barrantes-Vidal, N (reprint author), Univ Autonoma Barcelona, Dept Psicol Clin & Salut, E-08193 Barcelona, Spain.
EM neus.barrantes@uab.cat
RI Mitjavila, Merce/L-3760-2014; Kwapil, Thomas R./L-1127-2014; Sheinbaum,
   Tamara/A-8008-2016; Ballespi, Sergi/L-6492-2014; Kwapil,
   Thomas/I-3163-2019; Barrantes-Vidal, Neus/A-9578-2013
OI Mitjavila, Merce/0000-0003-2390-3774; Kwapil, Thomas
   R./0000-0003-1116-5954; Sheinbaum, Tamara/0000-0002-2268-7697; Ballespi,
   Sergi/0000-0002-6584-4138; Barrantes-Vidal, Neus/0000-0002-8671-1238
CR Barrantes-Vidal N, 2015, SCHIZOPHRENIA BULL, V41, pS408, DOI 10.1093/schbul/sbu191
   Beck A. T., 1996, MANUAL BECK DEPRESSI
   Bentall RP, 2014, SOC PSYCH PSYCH EPID, V49, P1011, DOI 10.1007/s00127-014-0914-0
   Berry K, 2007, CLIN PSYCHOL REV, V27, P458, DOI 10.1016/j.cpr.2006.09.006
   Bifulco A, 2005, BRIT J CLIN PSYCHOL, V44, P563, DOI 10.1348/014466505X35344
   Bifulco A, 2002, SOC PSYCH PSYCH EPID, V37, P50, DOI 10.1007/s127-002-8215-0
   BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x
   Bifulco A., 2013, UNDERSTANDING ADULT
   Bifulco A, 2006, SOC PSYCH PSYCH EPID, V41, P796, DOI 10.1007/s00127-006-0101-z
   Bifulco Antonia, 2002, Attach Hum Dev, V4, P180, DOI 10.1080/14616730210157501
   Bowlby J., 1973, ATTACHMENT LOSS, V2
   Brent BK, 2014, ISR J PSYCHIATR REL, V51, P17
   CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037//0021-843X.85.4.374
   CHAPMAN LJ, 1978, J ABNORM PSYCHOL, V87, P399, DOI 10.1037/0021-843X.87.4.399
   Chase N.D., 1999, BURDENED CHILDREN TH
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037//0033-2909.112.1.155
   Dozier M, 1991, DEV PSYCHOPATHOL, V3, P475, DOI DOI 10.1017/S0954579400007641
   ECKBLAD M, 1983, J CONSULT CLIN PSYCH, V51, P215, DOI 10.1037//0022-006X.51.2.215
   Eckblad M. L., 1982, REVISED SOCIAL UNPUB
   Egeland B, 2004, ATTACHMENT ISSUES IN PSYCHOPATHOLOGY AND INTERVENTION, P27
   First MB, 1997, STRUCTURED CLIN INTE
   Fisher HL, 2010, PSYCHOL MED, V40, P1967, DOI 10.1017/S0033291710000231
   Gumley AI, 2014, ACTA PSYCHIAT SCAND, V129, P257, DOI 10.1111/acps.12172
   Harris AE, 2002, COGNITIVE THER RES, V26, P405, DOI 10.1023/A:1016085112981
   Hayes A. F., 2013, INTRO MEDIATION MODE
   Janssen I, 2005, ACTA PSYCHIAT SCAND, V112, P372, DOI 10.1111/j.1600-0447.2005.00553.x
   Korver-Nieberg N, 2014, PSYCHOL PSYCHOTHER-T, V87, P127, DOI 10.1111/papt.12010
   Kwapil TR, 2015, SCHIZOPHRENIA BULL, V41, pS366, DOI 10.1093/schbul/sbu186
   Lewandowski KE, 2006, SCHIZOPHR RES, V83, P225, DOI 10.1016/j.schres.2005.11.024
   Macfie J, 2005, ATTACH HUM DEV, V7, P51, DOI 10.1080/14616730500039663
   Matheson SL, 2013, PSYCHOL MED, V43, P225, DOI 10.1017/S0033291712000785
   Mayseless O, 2004, FAM RELAT, V53, P78, DOI 10.1111/j.1741-3729.2004.00011.x
   McCabe KL, 2012, J PSYCHIATR RES, V46, P600, DOI 10.1016/j.jpsychires.2012.01.023
   Meins E, 2008, PERS INDIV DIFFER, V44, P1000, DOI 10.1016/j.paid.2007.10.026
   Mickelson KD, 1997, J PERS SOC PSYCHOL, V73, P1092, DOI 10.1037/0022-3514.73.5.1092
   Mikulincer M., 2007, ATTACHMENT ADULTHOOD
   RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555
   Read J, 2008, ATTACH NEW DIR PSYCH, V2, P1
   Roberts JE, 1996, J PERS SOC PSYCHOL, V70, P310, DOI 10.1037/0022-3514.70.2.310
   Sheinbaum T, SCHIZOTYPY IN PRESS
   Sheinbaum T, 2014, PSYCHIAT RES, V220, P691, DOI 10.1016/j.psychres.2014.07.030
   Siegel D. J, 2012, DEV MIND RELATIONSHI
   Sitko K, 2014, PSYCHIAT RES, V217, P202, DOI 10.1016/j.psychres.2014.03.019
   Smith B, 2006, SCHIZOPHR RES, V86, P181, DOI 10.1016/j.schres.2006.06.018
   Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141
   van Dam DS, 2014, SOC PSYCH PSYCH EPID, V49, P1759, DOI 10.1007/s00127-014-0894-0
   van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814
   van Winkel R, 2013, CAN J PSYCHIAT, V58, P44, DOI 10.1177/070674371305800109
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Velikonja T, 2015, PSYCHOL MED, V45, P947, DOI 10.1017/S0033291714002086
   Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x
NR 51
TC 5
Z9 5
U1 0
U2 29
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 6
PY 2015
VL 10
IS 8
AR e0135150
DI 10.1371/journal.pone.0135150
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO3MQ
UT WOS:000359062300105
PM 26247601
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU van Zelst, C
   van Nierop, M
   van Dam, DS
   Bartels-Velthuis, AA
   Delespaul, P
AF van Zelst, Catherine
   van Nierop, Martine
   van Dam, Daniella S.
   Bartels-Velthuis, Agna A.
   Delespaul, Philippe
CA GRP-Investigators
TI Associations between Stereotype Awareness, Childhood Trauma and
   Psychopathology: A Study in People with Psychosis, Their Siblings and
   Controls
SO PLOS ONE
LA English
DT Article
ID NEGATIVE-SYNDROME-SCALE; SEVERE MENTAL-ILLNESS; SELF-STIGMA;
   INTERNALIZED STIGMA; SCHIZOPHRENIA; EXPERIENCES; ESTEEM; MODEL;
   SENSITIVITY; ENVIRONMENT
AB Introduction
   Stereotype awareness-or an individual's perception of the degree to which negative beliefs or stereotypes are held by the public-is an important factor mediating public stigma, self-stigma and their negative consequences. Research is required to assess how individuals become more sensitive to perceive stereotypes, pointing the way to therapeutic options to reduce its negative effects and increase stigma resilience. Because perception and interpretation can be guided by belief systems, and childhood trauma (CT) is reported to impact such beliefs, CT is explored in relation to stereotype awareness (SA) in persons with psychosis, their siblings and controls.
   Method
   Data from the GROUP project (Genetic Risk and Outcome of Psychosis) were analyzed. SA was measured by devaluation scales which assess a respondent's perception of the degree to which stereotypes about people with mental illness and about their families are held by the public. CT was measured using the Childhood Trauma Questionnaire (short form).
   Results
   In patients, symptoms of disorganization and emotional distress were associated with SA about people with mental illness. In siblings, schizotypal features were associated with both types of SA (more schizotypy = more SA). In both patients and siblings, CT was associated with both types of SA (more CT = more SA), independent of symptoms (patients) or schizotypy (siblings).
   Conclusion
   CT in people with psychosis and their siblings may sensitize to SA. Thus, CT may not only impact on risk for illness onset, it may also increase SA associated with mental illness, potentially interfering with the recovery process. CT-induced SA may indicate a heightened sensitivity to threat, which may also impact psychopathology.
EM ph.delespaul@maastrichtuniversity.nl
RI Delespaul, Philippe/L-1396-2019; Myin-Germeys, Inez/L-5106-2014
OI Delespaul, Philippe/0000-0001-7420-0898; Bruggeman,
   Richard/0000-0002-3238-8471; van Nierop, Martine/0000-0003-2734-0550;
   Myin-Germeys, Inez/0000-0002-3731-4930
FU Geestkracht program of the Dutch Health Research Council (ZON-MW)
   [10-000-1002]; mental health care organizations (Site Amsterdam:
   Academic Psychiatric Centre AMC); mental health care organizations (Site
   Amsterdam: Ingeest); mental health care organizations (Site Amsterdam:
   Arkin); mental health care organizations (Site Amsterdam: Dijk en Duin);
   mental health care organizations (Site Amsterdam: Rivierduinen); mental
   health care organizations (Site Amsterdam: Erasmus MC); mental health
   care organizations (Site Amsterdam: GGZ Noord Holland Noord); mental
   health care organizations (Site Utrecht: University Medical Centre
   Utrecht); mental health care organizations (Site Utrecht: Altrecht);
   mental health care organizations (Site Utrecht: Symfora); mental health
   care organizations (Site Utrecht: Meerkanten); mental health care
   organizations (Site Utrecht: Riagg Amersfoort); mental health care
   organizations (Site Utrecht: Delta); mental health care organizations
   (Site Groningen: University Medical Centre Groningen); mental health
   care organizations (Site Groningen: Lentis); mental health care
   organizations (Site Groningen: GGZ Friesland); mental health care
   organizations (Site Groningen: GGZ Drenthe); mental health care
   organizations (Site Groningen: Dimence); mental health care
   organizations (Site Groningen: Mediant); mental health care
   organizations (Site Groningen: GGZ De Grote Rivieren); mental health
   care organizations (Site Groningen: Parnassia psychomedical centre);
   mental health care organizations (Site Maastricht: Maastricht University
   Medical Centre); mental health care organizations (Site Maastricht: GGZ
   Eindhoven); mental health care organizations (Site Maastricht: GGZ
   Midden-Brabant); mental health care organizations (Site Maastricht: GGZ
   Oost-Brabant); mental health care organizations (Site Maastricht: GGZ
   Noord-Midden Limburg); mental health care organizations (Site
   Maastricht: Mondriaan Zorggroep); mental health care organizations (Site
   Maastricht: Prins Clauscentrum Sittard); mental health care
   organizations (Site Maastricht: RIAGG Roermond); mental health care
   organizations (Site Maastricht: Universitair Centrum Sint-Jozef
   Kortenberg); mental health care organizations (Site Maastricht: CAPRI
   University of Antwerp); mental health care organizations (Site
   Maastricht: PC Ziekeren Sint-Truiden); mental health care organizations
   (Site Maastricht: PZ Sancta Maria Sint-Truiden); mental health care
   organizations (Site Maastricht: GGZ Overpelt); mental health care
   organizations (Site Maastricht: OPZ Rekem); Jansen-Cilag; Eli Lilly;
   Astra-Zeneca; Lundbeck; European Community [HEALTH-F2-2009-241909]
FX This work was supported by the Geestkracht program of the Dutch Health
   Research Council (ZON-MW, grant number 10-000-1002) and matching funds
   from participating universities and mental health care organizations
   (Site Amsterdam: Academic Psychiatric Centre AMC, Ingeest, Arkin, Dijk
   en Duin, Rivierduinen, Erasmus MC, GGZ Noord Holland Noord; Site
   Utrecht: University Medical Centre Utrecht, Altrecht, Symfora,
   Meerkanten, Riagg Amersfoort, Delta; Site Groningen: University Medical
   Centre Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant,
   GGZ De Grote Rivieren, and Parnassia psychomedical centre; Site
   Maastricht: Maastricht University Medical Centre, GGZ Eindhoven, GGZ
   Midden-Brabant, GGZ Oost-Brabant, GGZ Noord-Midden Limburg, Mondriaan
   Zorggroep, Prins Clauscentrum Sittard, RIAGG Roermond, Universitair
   Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren
   Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem).
   The analyses were supported by unrestricted grants from Jansen-Cilag,
   Eli Lilly and Company, Astra-Zeneca and Lundbeck. The research leading
   to these results has received funding from the European Community's
   Seventh Framework Program under grant agreement No.
   HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abrams Madeleine Seifter, 2009, Am J Psychother, V63, P305
   Ahmed AO, 2012, ACTA PSYCHIAT SCAND, V125, P54, DOI 10.1111/j.1600-0447.2011.01800.x
   American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT
   Beck AT, 1979, COGNITIVE THERAPY DE
   Bendall S, 2013, EARLY INTERV PSYCHIA, V7, P1, DOI 10.1111/eip.12008
   Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0
   Collip D, 2008, SCHIZOPHRENIA BULL, V34, P220, DOI 10.1093/schbul/sbm163
   Corrigan PW, 2006, J SOC CLIN PSYCHOL, V25, P875, DOI 10.1521/jscp.2006.25.8.875
   Corrigan PW, 2005, ON THE STIGMA OF MENTAL ILLNESS: PRACTICAL STRATEGIES FOR RESEARCH AND SOCIAL CHANGE, P11, DOI 10.1037/10887-001
   Crocker J., 1998, HDB SOCIAL PSYCHOL, V2, P504, DOI DOI 10.1002/9780470561119
   Downey G, 1996, J PERS SOC PSYCHOL, V70, P1327, DOI 10.1037/0022-3514.70.6.1327
   Ewertzon Mats, 2012, Issues Ment Health Nurs, V33, P157, DOI 10.3109/01612840.2011.633735
   Fallot RD, 2002, COMMUNITY MENT HLT J, V38, P475, DOI 10.1023/A:1020880101769
   Garety PA, 2001, PSYCHOL MED, V31, P189, DOI 10.1017/S0033291701003312
   Garety PA, 2007, PSYCHOL MED, V37, P1377, DOI 10.1017/S003329170700013X
   Goffman E., 1963, STIGMA NOTES MANAGEM
   Harvey MR, 1996, J TRAUMA STRESS, V9, P3, DOI 10.1002/jts.2490090103
   Hasson-Ohayon I, 2014, COMPR PSYCHIAT, V55, P675, DOI 10.1016/j.comppsych.2013.11.009
   Hasson-Ohayon I, 2012, PSYCHIAT RES, V200, P802, DOI 10.1016/j.psychres.2012.07.038
   Hasson-Ohayon I, 2011, COMPR PSYCHIAT, V52, P75, DOI 10.1016/j.comppsych.2010.04.008
   Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531
   Iwaniec D., 2006, CHILD FAMILY SOCIAL, V11, P73, DOI [10.1111/j.1365-2206.2006.00398.x, DOI 10.1111/J.1365-2206.2006.00398.X]
   KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261
   Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352
   Kranke DA, 2011, PSYCHIAT SERV, V62, P893, DOI 10.1176/ps.62.8.pss6208_0893
   Lardinois M, 2011, ACTA PSYCHIAT SCAND, V123, P28, DOI 10.1111/j.1600-0447.2010.01594.x
   Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363
   LINK BG, 1989, AM SOCIOL REV, V54, P400, DOI 10.2307/2095613
   Lysaker PH, 2007, PSYCHIAT RES, V149, P89, DOI 10.1016/j.psychres.2006.03.007
   Mak WWS, 2008, J APPL RES INTELLECT, V21, P532, DOI 10.1111/j.1468-3148.2008.00426.x
   Mashiach-Eizenberg M, 2013, PSYCHIAT RES, V208, P15, DOI 10.1016/j.psychres.2013.03.013
   Nabors LM, 2014, COMPR PSYCHIAT, V55, P792, DOI 10.1016/j.comppsych.2014.01.011
   Outcalt SD, 2012, PSYCHOSIS, V4, P32, DOI 10.1080/17522439.2011.591422
   Perlick DA, 2007, BRIT J PSYCHIAT, V190, P535, DOI 10.1192/bjp.bp.105.020826
   Pineles SL, 2007, BEHAV RES THER, V45, P1903, DOI 10.1016/j.brat.2006.08.021
   Pineles SL, 2009, BEHAV RES THER, V47, P1050, DOI 10.1016/j.brat.2009.08.001
   Platt M, 2012, PSYCHOL TRAUMA-US, V4, P370, DOI 10.1037/a0024253
   Read J, 2008, ATTACH NEW DIR PSYCH, V2, P1
   Roe D, 2010, J NERV MENT DIS, V198, P807, DOI 10.1097/NMD.0b013e3181f97c50
   Rosenbach C, 2011, VERHALTENSTHERAPIE, V21, P87, DOI 10.1159/000328839
   Rusch N, 2009, ACTA PSYCHIAT SCAND, V120, P320, DOI 10.1111/j.1600-0447.2009.01403.x
   Schneider DJ, 2004, PSYCHOL STEREOTYPING
   Schulze B, 2003, SOC SCI MED, V56, P299, DOI 10.1016/S0277-9536(02)00028-X
   Sin J, 2008, J PSYCHOSOC NURS, V46, P33, DOI 10.3928/02793695-20080601-11
   Stalberg G, 2004, SCHIZOPHRENIA BULL, V30, P445, DOI 10.1093/oxfordjournals.schbul.a007091
   StataCorp, 2009, STAT STAT SOFTW REL
   Struening FL, 2001, PSYCHIATR SERV, V52, P1633
   van der Gaag M, 2006, SCHIZOPHR RES, V85, P280, DOI 10.1016/j.schres.2006.03.021
   van Zelst C, 2008, SCHIZOPHRENIA BULL, V34, P1106, DOI 10.1093/schbul/sbn113
   van Zelst C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088586
   vandeBongardt Daphne, 2014, PERSONALITY SOCIAL P, V19, P1, DOI 10.1186/1687-9856-2014-15
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482
   Yanos PT, 2012, PSYCHOL SERV, V9, P248, DOI 10.1037/a0028048
NR 54
TC 4
Z9 4
U1 2
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 23
PY 2015
VL 10
IS 2
AR UNSP e0117386
DI 10.1371/journal.pone.0117386
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC9BI
UT WOS:000350662100085
PM 25705878
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Nicol, K
   Pope, M
   Sprengelmeyer, R
   Young, AW
   Hall, J
AF Nicol, Katie
   Pope, Merrick
   Sprengelmeyer, Reiner
   Young, Andrew W.
   Hall, Jeremy
TI Social Judgement in Borderline Personality Disorder
SO PLOS ONE
LA English
DT Article
ID CHILDHOOD TRAUMA; BRAIN ABNORMALITIES; AMYGDALA; COGNITION; FACE;
   MENTALIZATION; SCHIZOPHRENIA; METAANALYSIS; NEUROBIOLOGY; ATTACHMENT
AB Background: Borderline personality disorder (BPD) is a common and serious mental illness, associated with a high risk of suicide and self harm. Those with a diagnosis of BPD often display difficulties with social interaction and struggle to form and maintain interpersonal relationships. Here we investigated the ability of participants with BPD to make social inferences from faces.
   Method: 20 participants with BPD and 21 healthy controls were shown a series of faces and asked to judge these according to one of six characteristics (age, distinctiveness, attractiveness, intelligence, approachability, trustworthiness). The number and direction of errors made (compared to population norms) were recorded for analysis.
   Results: Participants with a diagnosis of BPD displayed significant impairments in making judgements from faces. In particular, the BPD Group judged faces as less approachable and less trustworthy than controls. Furthermore, within the BPD Group there was a correlation between scores on the Childhood Trauma Questionnaire (CTQ) and bias towards judging faces as unapproachable.
   Conclusion: Individuals with a diagnosis of BPD have difficulty making appropriate social judgements about others from their faces. Judging more faces as unapproachable and untrustworthy indicates that this group may have a heightened sensitivity to perceiving potential threat, and this should be considered in clinical management and treatment.
C1 [Nicol, Katie; Hall, Jeremy] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland.
   [Pope, Merrick] Royal Edinburgh & Associated Hosp, Edinburgh, Midlothian, Scotland.
   [Sprengelmeyer, Reiner] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland.
   [Young, Andrew W.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.
   [Hall, Jeremy] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff CF10 3AX, S Glam, Wales.
RP Nicol, K (reprint author), Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland.
EM K.Nicol-3@staffmail.ed.ac.uk
RI Young, Andy/G-2189-2011
OI Young, Andy/0000-0002-1202-6297; Hall, Jeremy/0000-0002-0403-3278
FU Chief Scientist Office (Scotland) [SCD/10]; Scottish Senior Clinical
   Fellowship; Chief Scientist Office [SCD/10]
FX Although the study itself was not directly funded, Professor Jeremy Hall
   is supported by a Chief Scientist Office (Scotland) grant (No: SCD/10),
   and by a Scottish Senior Clinical Fellowship. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6
   Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982
   Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884
   Ball JS, 2009, CURR PSYCHIAT REP, V11, P63, DOI 10.1007/s11920-009-0010-4
   Bateman A, 2010, WORLD PSYCHIATRY, V9, P11
   Billeke Pablo, 2013, Front Psychiatry, V4, P4, DOI 10.3389/fpsyt.2013.00004
   Bland Ann R, 2004, Issues Ment Health Nurs, V25, P655, DOI 10.1080/01612840490486692
   Brunner R, 2010, NEUROIMAGE, V49, P114, DOI 10.1016/j.neuroimage.2009.07.070
   Choi-Kain LW, 2008, AM J PSYCHIAT, V165, P1127, DOI 10.1176/appi.ajp.2008.07081360
   Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021
   Domes G, 2008, J PERS DISORD, V22, P135, DOI 10.1521/pedi.2008.22.2.135
   Donegan NH, 2003, BIOL PSYCHIAT, V54, P1284, DOI 10.1016/S0006-3223(03)00636-X
   Fertuck EA, 2009, PSYCHOL MED, V39, P1979, DOI 10.1017/S003329170900600X
   Fonagy P, 2011, INFANT MENT HEALTH J, V32, P47, DOI 10.1002/imhj.20283
   Grant MM, 2011, J PSYCHIATR RES, V45, P886, DOI 10.1016/j.jpsychires.2010.12.004
   Hall J, 2004, BRIT J PSYCHIAT, V185, P169, DOI 10.1192/bjp.185.2.169
   Hall J, 2010, PSYCHOL MED, V40, P1183, DOI 10.1017/S0033291709991395
   Hall J, 2010, PERSONAL MENT HEALTH, V4, P172, DOI 10.1002/pmh.128
   Hammersley P, 2003, BRIT J PSYCHIAT, V182, P543, DOI 10.1192/bjp.182.6.543
   HILL J, 2010, PSYCHOL MED, V38, P135
   Leichsenring F, 2011, LANCET, V377, P74, DOI 10.1016/S0140-6736(10)61422-5
   Levine D, 1997, J NERV MENT DIS, V185, P240, DOI 10.1097/00005053-199704000-00004
   Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6
   Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406
   Martens MA, 2009, NEUROPSYCHOLOGIA, V47, P2446, DOI 10.1016/j.neuropsychologia.2009.04.017
   Marwick K, 2008, BRIT MED BULL, V88, P43, DOI 10.1093/bmb/ldn035
   Mauchnik J, 2010, CURR PSYCHIAT REP, V12, P46, DOI 10.1007/s11920-009-0089-7
   McDonald S., 2013, J INT NEUROPSYCH SOC, V19, P1, DOI DOI 10.1017/S1355617713000428.PUBMED:23351330
   Meyer B, 2004, J PERS DISORD, V18, P320, DOI 10.1521/pedi.18.4.320.40344
   Minzenberg MJ, 2007, PSYCHIAT RES-NEUROIM, V155, P231, DOI 10.1016/j.pseychresns.2007.03.006
   New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283
   Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333
   Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105
   Philip RCM, 2010, PSYCHOL MED, V40, P1919, DOI 10.1017/S0033291709992364
   Preissler S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00182
   Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x
   Santos IM, 2008, PERCEPTION, V37, P1061, DOI 10.1068/p5278
   Soloff P, 2008, PSYCHIAT RES-NEUROIM, V164, P223, DOI 10.1016/j.pscychresns.2008.02.003
   Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009
   Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001
   van Elst LT, 2003, BIOL PSYCHIAT, V54, P163, DOI 10.1016/S0006-3223(03)01743-2
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3
   Wolf RC, 2011, J PSYCHIATR NEUROSCI, V36, P402, DOI 10.1503/jpn.100150
   Young AW, 2011, BRIT J PSYCHOL, V102, P959, DOI 10.1111/j.2044-8295.2011.02045.x
   Zanarini MC, 2010, ACTA PSYCHIAT SCAND, V122, P103, DOI 10.1111/j.1600-0447.2010.01543.x
NR 48
TC 13
Z9 14
U1 0
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 6
PY 2013
VL 8
IS 11
AR UNSP e73440
DI 10.1371/journal.pone.0073440
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 247XD
UT WOS:000326656200002
PM 24223110
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU van Nierop, M
   Janssens, M
   Bruggeman, R
   Cahn, W
   de Haan, L
   Kahn, RS
   Meijer, CJ
   Myin-Germeys, I
   van Os, J
   Wiersma, D
AF van Nierop, Martine
   Janssens, Mayke
   Bruggeman, Richard
   Cahn, Wiepke
   de Haan, Lieuwe
   Kahn, Rene S.
   Meijer, Carin J.
   Myin-Germeys, Inez
   van Os, Jim
   Wiersma, Durk
CA Genetic Risk OUtcome Psychosis GRP
TI Evidence That Transition from Health to Psychotic Disorder Can Be Traced
   to Semi-Ubiquitous Environmental Effects Operating against Background
   Genetic Risk
SO PLOS ONE
LA English
DT Article
ID FAMILIAL LIABILITY; CHILDHOOD TRAUMA; PREMORBID ADJUSTMENT; NEGATIVE
   SYMPTOMS; CANNABIS USE; SCHIZOPHRENIA; METAANALYSIS; URBANICITY;
   EXPERIENCES; POPULATION
AB Background: In order to assess the importance of environmental and genetic risk on transition from health to psychotic disorder, a prospective study of individuals at average (n=462) and high genetic risk (n=810) was conducted.
   Method: A three-year cohort study examined the rate of transition to psychotic disorder. Binary measures indexing environmental exposure (combining urban birth, cannabis use, ethnicity and childhood trauma) and proxy genetic risk (high-risk sibling status) were used to model transition.
   Results: The majority of high-risk siblings (68%) and healthy comparison subjects (60%) had been exposed to one or more environmental risks. The risk of transition in siblings (n=9, 1.1%) was higher than the risk in healthy comparison subjects (n=2, 0.4%; ORadj=2.2,95% CI: 5-10.3). All transitions (100%) were associated with environmental exposure, compared to 65% of non-transitions (p=0.014), with the greatest effects for childhood trauma (ORadj=34.4,95% CI: 4.4-267.4), cannabis use (OR=4.1,95% CI: 1.1, 15.4), minority ethnic group (OR=3.8,95% CI: 1.2,12.8) and urban birth (OR=3.7,95% CI: 0.9,15.4). The proportion of transitions in the population attributable to environmental and genetic risk ranged from 28% for minority ethnic group, 45% for urban birth, 57% for cannabis use, 86% for childhood trauma, and 50% for high-risk sibling status. Nine out of 11 transitions (82%) were exposed to both genetic and environmental risk, compared to only 43% of non-transitions (p=0.03).
   Conclusion: Environmental risk associated with transition to psychotic disorder is semi-ubiquitous regardless of genetic high risk status. Careful prospective documentation suggests most transitions can be attributed to powerful environmental effects that become detectable when analysed against elevated background genetic risk, indicating gene-environment interaction.
C1 [van Nierop, Martine; Janssens, Mayke; Myin-Germeys, Inez; van Os, Jim] Maastricht Univ Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, Maastricht, Netherlands.
   [Bruggeman, Richard; Wiersma, Durk] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands.
   [Cahn, Wiepke; Kahn, Rene S.] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.
   [de Haan, Lieuwe; Meijer, Carin J.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands.
   [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London, England.
RP van Os, J (reprint author), Maastricht Univ Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, Maastricht, Netherlands.
EM j.vanos@maastrichtuniversity.nl
RI Myin-Germeys, Inez/L-5106-2014
OI Myin-Germeys, Inez/0000-0002-3731-4930; Bruggeman,
   Richard/0000-0002-3238-8471; van Nierop, Martine/0000-0003-2734-0550
FU Dutch Health Research Council (ZON-MW) [10-000-1002]; Site Amsterdam:
   Academic Psychiatric Centre AMC; Site Amsterdam: Ingeest; Site
   Amsterdam: Arkin; Site Amsterdam: Dijk en Duin; Site Amsterdam:
   Rivierduinen; Site Amsterdam: Erasmus MC; Site Amsterdam: GGZ Noord
   Holland Noord; Site Utrecht: University Medical Centre Utrecht; Site
   Utrecht: Altrecht; Site Utrecht: Symfora; Site Utrecht: Meerkanten; Site
   Utrecht: Riagg Amersfoort; Site Utrecht: Delta; Site Groningen:
   University Medical Centre Groningen; Site Groningen: Lentis; Site
   Groningen: GGZ Friesland; Site Groningen: GGZ Drenthe; Site Groningen:
   Dimence; Site Groningen: Mediant; Site Groningen: GGZ De Grote Rivieren;
   Site Groningen: Parnassia psycho-medical centre; Site Maastricht:
   Maastricht University Medical Centre; Site Maastricht: GGZ Eindhoven;
   Site Maastricht: GGZ Midden-Brabant; Site Maastricht: GGZ Oost-Brabant;
   Site Maastricht: GGZ Noord- Midden Limburg; Site Maastricht: Mondriaan
   Zorggroep; Site Maastricht: Prins Clauscentrum Sittard; Site Maastricht:
   RIAGG Roermond; Site Maastricht: Universitair Centrum Sint-Jozef
   Kortenberg; Site Maastricht: CAPRI University of Antwerp; Site
   Maastricht: PC Ziekeren Sint-Truiden; Site Maastricht: PZ Sancta Maria
   Sint-Truiden; Site Maastricht: GGZ Overpelt; Site Maastricht: OPZ Rekem;
   Jansen-Cilag; Eli Lilly and Company; Astra-Zeneca; Lundbeck; European
   Community [HEALTH-F2-2009-241909]
FX This work was supported by the Geestkracht program of the Dutch Health
   Research Council (ZON-MW, grant number 10-000-1002) and matching funds
   from participating universities and mental health care organizations
   (Site Amsterdam: Academic Psychiatric Centre AMC, Ingeest, Arkin, Dijk
   en Duin, Rivierduinen, Erasmus MC, GGZ Noord Holland Noord; Site
   Utrecht: University Medical Centre Utrecht, Altrecht, Symfora,
   Meerkanten, Riagg Amersfoort, Delta; Site Groningen: University Medical
   Centre Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant,
   GGZ De Grote Rivieren and Parnassia psycho-medical centre; Site
   Maastricht: Maastricht University Medical Centre, GGZ Eindhoven, GGZ
   Midden-Brabant, GGZ Oost-Brabant, GGZ Noord- Midden Limburg, Mondriaan
   Zorggroep, Prins Clauscentrum Sittard, RIAGG Roermond, Universitair
   Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren
   Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem).
   The analyses were supported by unrestricted grants from Jansen-Cilag,
   Eli Lilly and Company, Astra-Zeneca and Lundbeck. The research leading
   to these results has received funding from the European Community's
   Seventh Framework Program under grant agreement No.
   HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615
   ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784
   Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012
   Blyler CR, 2000, SCHIZOPHR RES, V46, P209, DOI 10.1016/S0920-9964(00)00017-7
   Brill N, 2008, SCHIZOPHRENIA BULL, V34, P981, DOI 10.1093/schbul/sbm128
   Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024
   Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080
   CANNONSPOOR HE, 1982, SCHIZOPHRENIA BULL, V8, P470, DOI 10.1093/schbul/8.3.470
   Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12
   Clarke MC, 2009, AM J PSYCHIAT, V166, P1025, DOI 10.1176/appi.ajp.2009.08010031
   Cougnard A, 2007, PSYCHOL MED, V37, P513, DOI 10.1017/S0033291706009731
   Cutajar MC, 2010, ARCH GEN PSYCHIAT, V67, P1114, DOI 10.1001/archgenpsychiatry.2010.147
   Elklit A, 2011, SCHIZOPHRENIA BULL, V37, P1305, DOI 10.1093/schbul/sbq048
   Fusar-Poli P, 2013, ACTA PSYCHIAT SCAND, V127, P248, DOI 10.1111/acps.12028
   Fusar-Poli P, 2014, SCHIZOPHRENIA BULL, V40, P120, DOI 10.1093/schbul/sbs136
   Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P220, DOI 10.1001/archgenpsychiatry.2011.1472
   Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010
   Harley M, 2010, PSYCHOL MED, V40, P1627, DOI 10.1017/S0033291709991966
   Heaton RK, 2001, ARCH GEN PSYCHIAT, V58, P24, DOI 10.1001/archpsyc.58.1.24
   Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531
   Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x
   Johnstone EC, 2005, BRIT J PSYCHIAT, V186, P18, DOI 10.1192/bjp.186.1.18
   Kahn RS, 2011, ARCH GEN PSYCHIAT, V68, P138, DOI 10.1001/archgenpsychiatry.2010.132
   Kahn RS, JAMA IN PRESS
   Kaymaz N, 2012, PSYCHOL MED, V42, P2239, DOI 10.1017/S0033291711002911
   Kirkbride JB, 2012, EPIGENOMICS-UK, V4, P303, DOI [10.2217/EPI.12.20, 10.2217/epi.12.20]
   Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352
   Marcelis M, 1999, PSYCHOL MED, V29, P1197, DOI 10.1017/S0033291799008983
   Matheson SL, 2011, SCHIZOPHR RES, V133, P133, DOI 10.1016/j.schres.2011.09.020
   McGorry P, 2013, LANCET, V381, P343, DOI 10.1016/S0140-6736(12)61268-9
   McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101
   Musshoff F, 2006, THER DRUG MONIT, V28, P155, DOI 10.1097/01.ftd.0000197091.07807.22
   NIMH Genetics Initiative, 1992, FAM INT GEN STUD FIG
   Peraala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19
   Purcell SM, 2009, NATURE
   Read J, 2012, BRIT J PSYCHIAT, V200, P89, DOI 10.1192/bjp.bp.111.096727
   Russell AJ, 1997, AM J PSYCHIAT, V154, P635
   Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23
   SELTEN JPCJ, 1993, COMPR PSYCHIAT, V34, P192, DOI 10.1016/0010-440X(93)90047-8
   SMALL NE, 1984, BIOL PSYCHIAT, V19, P203
   StataCorp, 2011, STAT STAT SOFTW REL
   The WHOQOL Group, 1998, PSYCHOL MED, V28, P551
   van Nierop M, 2012, SCHIZOPHRENIA BULL, V38, P231, DOI 10.1093/schbul/sbr129
   van Os J, 2003, AM J PSYCHIAT, V160, P477, DOI 10.1176/appi.ajp.160.3.477
   van Os J, 2004, AM J PSYCHIAT, V161, P2312, DOI 10.1176/appi.ajp.161.12.2312
   van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Vassos E, 2012, SCHIZOPHRENIA BULL, V38, P1118, DOI 10.1093/schbul/sbs096
   Velthorst E, 2012, COGN NEUROPSYCHIATRY
   Weiser M, 2007, BRIT J PSYCHIAT, V191, P320, DOI 10.1192/bjp.bp.106.031328
   Welch KA, 2011, BRIT J PSYCHIAT, V199, P386, DOI 10.1192/bjp.bp.110.090175
   WHO, 1990, COMP INT DIAGN INT C
   Wicks S, 2005, AM J PSYCHIAT, V162, P1652, DOI 10.1176/appi.ajp.162.9.1652
   Wing J. K., 1974, MEASUREMENT CLASSIFI
   WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589
NR 56
TC 18
Z9 18
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 6
PY 2013
VL 8
IS 11
AR e76690
DI 10.1371/journal.pone.0076690
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 247XD
UT WOS:000326656200008
PM 24223116
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Ramsay, H
   Kelleher, I
   Flannery, P
   Clarke, MC
   Lynch, F
   Harley, M
   Connor, D
   Fitzpatrick, C
   Morris, DW
   Cannon, M
AF Ramsay, Hugh
   Kelleher, Ian
   Flannery, Padraig
   Clarke, Mary C.
   Lynch, Fionnuala
   Harley, Michelle
   Connor, Dearbhla
   Fitzpatrick, Carol
   Morris, Derek W.
   Cannon, Mary
TI Relationship between the COMT-Val158Met and BDNF-Val66Met Polymorphisms,
   Childhood Trauma and Psychotic Experiences in an Adolescent General
   Population Sample
SO PLOS ONE
LA English
DT Article
ID CATECHOL-O-METHYLTRANSFERASE; COMT VAL(158)MET MODERATION; HYPERACTIVITY
   DISORDER ADHD; DELUSIONAL-LIKE EXPERIENCES; ENZYME-ACTIVITY;
   MENTAL-HEALTH; CANNABIS USE; RISK-FACTOR; SYMPTOMS; ASSOCIATION
AB Objective: Psychotic experiences occur at a much greater prevalence in the population than psychotic disorders. There has been little research to date, however, on genetic risk for this extended psychosis phenotype. We examined whether COMT or BDNF genotypes were associated with psychotic experiences or interacted with childhood trauma in predicting psychotic experiences.
   Method: Psychiatric interviews and genotyping for COMT-Val158Met and BDNF-Val66Met were carried out on two population-based samples of 237 individuals aged 11-15 years. Logistic regression was used to examine for main effects by genotype and childhood trauma, controlling for important covariates. This was then compared to a model with a term for interaction between genotype and childhood trauma. Where a possible interaction was detected, this was further explored in stratified analyses.
   Results: While childhood trauma showed a borderline association with psychotic experiences, COMT-Val158Met and BDNF-Val66Met genotypes were not directly associated with psychotic experiences in the population. Testing for gene x environment interaction was borderline significant in the case of COMT-Val158Met with individuals with the COMT-Val158Met Val-Val genotype, who had been exposed to childhood trauma borderline significantly more likely to report psychotic experiences than those with Val-Met or Met-Met genotypes. There was no similar interaction by BDNF-Val66Met genotype.
   Conclusion: The COMT-Val158Met Val-Val genotype may be a genetic moderator of risk for psychotic experiences in individuals exposed to childhood traumatic experiences.
C1 [Ramsay, Hugh; Kelleher, Ian; Flannery, Padraig; Clarke, Mary C.; Harley, Michelle; Connor, Dearbhla; Cannon, Mary] Beaumont Hosp, Royal Coll Surg Ireland, Dept Psychiat, Dublin 9, Ireland.
   [Kelleher, Ian] Karolinska Inst, Natl Ctr Suicide Res & Prevent Mental Hlth 3, Stockholm, Sweden.
   [Lynch, Fionnuala] Lucena Clin, Dublin, Ireland.
   [Harley, Michelle] St Vincents Hosp, Dept Child & Adolescent Psychiat, Dublin 4, Ireland.
   [Fitzpatrick, Carol] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland.
   [Morris, Derek W.] Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin, Ireland.
   [Morris, Derek W.] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland.
RP Ramsay, H (reprint author), Beaumont Hosp, Royal Coll Surg Ireland, Dept Psychiat, Dublin 9, Ireland.
EM drhughramsay@gmail.com
RI Cannon, Mary/D-8227-2012
OI Cannon, Mary/0000-0002-0910-299X; Morris, Derek/0000-0002-3413-570X;
   Kelleher, Ian/0000-0003-1484-651X
FU European Communities Seventh Framework Programme
   [HEALTH-F2-2010-241909]; Health Research Board (Ireland) [CSA/2004/1];
   Friends of the Children's University Hospital (Dublin); American
   Foundation for Suicide Prevention; HSE Northern Area; Mater
   Misericordiae University Hospital
FX The research leading to these results has received funding from the
   European Communities Seventh Framework Programme under grant agreement
   HEALTH-F2-2010-241909 (Project EU-GEI); EU-GEI is the acronym of the
   project European Network of National Schizophrenia Networks Studying
   Gene-Environment Interactions. This work was supported by a Clinician
   Scientist Award to Dr Cannon (CSA/2004/1) from the Health Research Board
   (Ireland). The original Challenging Times study was funded by Friends of
   the Children's University Hospital (Dublin), the American Foundation for
   Suicide Prevention, HSE Northern Area and the Mater Misericordiae
   University Hospital. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aguilera M, 2009, PSYCHOL MED, V39, P1425, DOI 10.1017/S0033291709005248
   Alemany S, 2011, BRIT J PSYCHIAT, V199, P38, DOI 10.1192/bjp.bp.110.083808
   Bebbington PE, 2004, BRIT J PSYCHIAT, V185, P220, DOI 10.1192/bjp.185.3.220
   Bendall S, 2008, SCHIZOPHRENIA BULL, V34, P568, DOI 10.1093/schbul/sbm121
   Binbay T, 2012, SCHIZOPHRENIA BULL, V38, P992, DOI 10.1093/schbul/sbr003
   Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026
   Caspi A, 2008, ARCH GEN PSYCHIAT, V65, P203, DOI 10.1001/archgenpsychiatry.2007.24
   Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589
   Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663
   Eisenberg J, 1999, AM J MED GENET, V88, P497, DOI 10.1002/(SICI)1096-8628(19991015)88:5<497::AID-AJMG12>3.3.CO;2-6
   Fisher HL, 2013, PSYCHOL MED, V43, P2077, DOI 10.1017/S0033291712003091
   Gale CK, 2011, ACTA PSYCHIAT SCAND, V124, P205, DOI 10.1111/j.1600-0447.2011.01707.x
   Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015
   Harley M, 2010, PSYCHOL MED, V40, P1627, DOI 10.1017/S0033291709991966
   HARLEY M, 2013, IR J MED SC IN PRESS
   Hawi Z, 2000, AM J MED GENET, V96, P282, DOI 10.1002/1096-8628(20000612)96:3<282::AID-AJMG9>3.0.CO;2-R
   Henquet C, 2009, ACTA PSYCHIAT SCAND, V119, P156, DOI 10.1111/j.1600-0447.2008.01265.x
   Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x
   Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572
   KAUFMAN J, 1996, SCHEDULE AFFECTIVE D
   Kelleher I, 2012, PSYCHOL MED, V42, P1857, DOI 10.1017/S0033291711002960
   Kelleher I, 2012, BRIT J PSYCHIAT, V201, P26, DOI 10.1192/bjp.bp.111.101543
   Kelleher I, 2011, PSYCHOL MED, V41, P1, DOI 10.1017/S0033291710001005
   Kelleher I, 2008, BRIT J PSYCHIAT, V193, P378, DOI 10.1192/bjp.bp.108.049536
   Kelleher I, 2013, AM J PSYCHIAT, V170, P734, DOI 10.1176/appi.ajp.2012.12091169
   Kelleher I, 2012, ARCH GEN PSYCHIAT, V69, P1277, DOI 10.1001/archgenpsychiatry.2012.164
   Kelleher I, 2012, SCHIZOPHRENIA BULL, V38, P239, DOI 10.1093/schbul/sbr164
   Kelleher I, 2010, BRIT J PSYCHIAT, V197, P167, DOI 10.1192/bjp.bp.109.076018
   Kia-Keating BM, 2007, AM J MED GENET B, V144B, P1048, DOI 10.1002/ajmg.b.30551
   Kirov G, 1998, MOL PSYCHIATR, V3, P342, DOI 10.1038/sj.mp.4000385
   Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275
   Kolassa IT, 2010, BIOL PSYCHIAT, V67, P304, DOI 10.1016/j.biopsych.2009.10.009
   KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995
   Kovacs M., 1992, CHILDRENS DEPRESSION
   Lataster T, 2006, SOC PSYCH PSYCH EPID, V41, P423, DOI 10.1007/s00127-006-0060-4
   Laurens KR, 2012, PSYCHOL MED, V42, P1495, DOI 10.1017/S0033291711002108
   Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626
   Lynch F, 2006, J ADOLESCENCE, V29, P555, DOI 10.1016/j.adolescence.2005.08.011
   MANDELLI L, 2013, NEUROSCI BIOBEHAV R
   Meira-Lima I, 2004, GENES BRAIN BEHAV, V3, P75, DOI 10.1046/j.1601-183x.2003.00042.x
   Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053
   Nishida A, 2010, ACTA PSYCHIAT SCAND, V121, P301, DOI 10.1111/j.1600-0447.2009.01439.x
   Nurjono Milawaty, 2012, Clin Psychopharmacol Neurosci, V10, P61, DOI 10.9758/cpn.2012.10.2.61
   Peerbooms O, 2012, ACTA PSYCHIAT SCAND, V125, P247, DOI 10.1111/j.1600-0447.2011.01806.x
   Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14
   Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053
   Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x
   Saha S, 2011, SCHIZOPHR RES, V132, P197, DOI 10.1016/j.schres.2011.07.012
   Savitz J, 2010, BEHAV GENET, V40, P415, DOI 10.1007/s10519-009-9323-7
   Scott J, 2009, AM J PSYCHIAT, V166, P567, DOI 10.1176/appi.ajp.2008.08081182
   Scott J, 2009, SCHIZOPHR RES, V107, P179, DOI 10.1016/j.schres.2008.11.002
   Shoval G, 2005, EUR NEUROPSYCHOPHARM, V15, P319, DOI 10.1016/j.euroneuro.2004.12.005
   Simons CJP, 2009, GENES BRAIN BEHAV, V8, P5, DOI 10.1111/j.1601-183X.2008.00434.x
   Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217
   Spataro J, 2004, BRIT J PSYCHIAT, V184, P416, DOI 10.1192/bjp.184.5.416
   Spauwen J, 2006, BRIT J PSYCHIAT, V188, P527, DOI 10.1192/bjp.bp.105.011346
   Stefanis NC, 2007, PSYCHOL MED, V37, P1651, DOI 10.1017/S0033291707001080
   Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024
   van Dam DS, 2012, PSYCHOL MED, V42, P2463, DOI 10.1017/S0033291712000360
   van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Varghese D, 2013, ACTA PSYCHIAT SCAND, V127, P48, DOI 10.1111/j.1600-0447.2012.01905.x
   VINKERS CH, 2013, SCHIZOPHR RES
   Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19
   Welham J, 2009, PSYCHOL MED, V39, P625, DOI 10.1017/S0033291708003760
   Werbeloff N, 2012, ARCH GEN PSYCHIAT, V69, P467, DOI 10.1001/archgenpsychiatry.2011.1580
   Wigman JTW, 2012, ACTA PSYCHIAT SCAND, V126, P266, DOI 10.1111/j.1600-0447.2012.01857.x
   Wigman JTW, 2012, SCHIZOPHRENIA BULL, V38, P247, DOI 10.1093/schbul/sbr196
   Williams HJ, 2007, SCHIZOPHRENIA BULL, V33, P635, DOI 10.1093/schbul/sbm019
   Zammit S, 2011, BRIT J PSYCHIAT, V199, P380, DOI 10.1192/bjp.bp.111.091421
NR 70
TC 14
Z9 14
U1 0
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 5
PY 2013
VL 8
IS 11
AR UNSP e79741
DI 10.1371/journal.pone.0079741
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 247EE
UT WOS:000326597400084
PM 24224001
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Wigman, JTW
   Collip, D
   Wichers, M
   Delespaul, P
   Derom, C
   Thiery, E
   Vollebergh, WAM
   Lataster, T
   Jacobs, N
   Myin-Germeys, I
   van Os, J
AF Wigman, Johanna T. W.
   Collip, Dina
   Wichers, Marieke
   Delespaul, Philippe
   Derom, Catherine
   Thiery, Evert
   Vollebergh, Wilma A. M.
   Lataster, Tineke
   Jacobs, Nele
   Myin-Germeys, Inez
   van Os, Jim
TI Altered Transfer of Momentary Mental States (ATOMS) as the Basic Unit of
   Psychosis Liability in Interaction with Environment and Emotions
SO PLOS ONE
LA English
DT Article
ID DAILY-LIFE STRESS; GENERAL-POPULATION; CHILDHOOD TRAUMA; POSITIVE
   EMOTIONS; COGNITIVE MODEL; GENETIC RISK; SCHIZOPHRENIA; DEPRESSION;
   REACTIVITY; SYMPTOMS
AB Psychotic disorders are thought to represent altered neural function. However, research has failed to map diagnostic categories to alterations in neural networks. It is proposed that the basic unit of psychotic psychopathology is the moment-to-moment expression of subtle anomalous experiences of subclinical psychosis, and particularly its tendency to persist from moment-to-moment in daily life, under the influence of familial, environmental, emotional and cognitive factors. In a general population twin sample (n =579) and in a study of patients with psychotic disorder (n = 57), their non-psychotic siblings (n = 59) and unrelated controls (n = 75), the experience sampling paradigm (ESM; repetitive, random sampling of momentary mental states and context) was applied. We analysed, in a within-person prospective design, (i) transfer of momentary anomalous experience at time point (t-1) to time point (t) in daily life, and (ii) moderating effects of negative affect, positive affect, daily stressors, IQ and childhood trauma. Additionally, (iii) familial associations between persistence of momentary anomalous experience and psychotic symptomatology were investigated. Higher level of schizotypy in the twins (but not higher level of psychotic symptoms in patients) predicted more persistence of momentary anomalous experience in daily life, both within subjects and across relatives. Persistence of momentary anomalous experience was highest in patients, intermediate in their siblings and lowest in controls. In both studies, persistence of momentary anomalous experience was moderated by higher levels of negative affect, daily stressors and childhood trauma (only in twins), and by lower levels of positive affect. The study of alterations in the moment-to-moment transfer of subtle anomalous experience of psychosis, resulting in their persistence, helps to explain why psychotic and emotional dysregulation tend to cluster in a single phenotype such as schizophrenia, and how familial and environmental risks increase the risk of expression of psychosis from, first, subtle momentary anomalous experience to, second, observable clinical symptoms.
C1 [Wigman, Johanna T. W.; Collip, Dina; Wichers, Marieke; Delespaul, Philippe; Lataster, Tineke; Jacobs, Nele; Myin-Germeys, Inez; van Os, Jim] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.
   [Wigman, Johanna T. W.; Vollebergh, Wilma A. M.] Univ Utrecht, Dept Interdisciplinary Social Sci, Utrecht, Netherlands.
   [Derom, Catherine] Catholic Univ, Dept Human Genet, Univ Hosp Gasthuisberg, Louvain, Belgium.
   [Thiery, Evert] Assoc Sci Res Multiple Births, Ghent, Belgium.
   [Jacobs, Nele] Open Univ Netherlands, Fac Psychol, Heerlen, Netherlands.
   [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Kings Hlth Partners, Inst Psychiat, London WC2R 2LS, England.
RP van Os, J (reprint author), Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.
EM j.vanos@maastrichtuniversity.nl
RI Delespaul, Philippe/L-1396-2019; Wichers, Marieke/N-6667-2014;
   Myin-Germeys, Inez/L-5106-2014
OI Delespaul, Philippe/0000-0001-7420-0898; Wichers,
   Marieke/0000-0001-5024-9064; Myin-Germeys, Inez/0000-0002-3731-4930;
   Derom, Catherine/0000-0001-5574-796X
FU Fund of Scientific Research; Flanders; Twins, a non-profit association
   for Scientific Research in Multiple Births (Belgium); Geestkracht
   program of the Netherlands Organization for Health Research and
   Development (ZonMw) [10-000-1002]; European Community's Seventh
   Framework Program [HEALTH-F2-2009-241909]; Janssen-Cilag; Eli Lilly and
   Co; AstraZeneca; Lundbeck
FX The TWIN study has been partly supported by grants from the Fund of
   Scientific Research, Flanders and Twins, a non-profit association for
   Scientific Research in Multiple Births (Belgium). The infrastructure for
   the GROUP study is funded by grant 10-000-1002 from the Geestkracht
   program of the Netherlands Organization for Health Research and
   Development (ZonMw) and matching funds from participating universities
   and mental health care organizations (Site Amsterdam: Academic
   Psychiatric Centre AMC, Ingeest, Arkin, Dijk en Duin, Rivierduinen,
   Erasmus MC, GGZ Noord Holland Noord; Site Utrecht: University Medical
   Centre Utrecht, Altrecht, Symfora, Meerkanten, Riagg Amersfoort, Delta;
   Site Groningen: University Medical Center Groningen, Lentis, GGZ
   Friesland, GGZ Drenthe, Dimence, Mediant, GGZ De Grote Rivieren, and
   Parnassia Psychomedical Centre; Site Maastricht: Maastricht University
   Medical Center, GGZ Eindhoven, GGZ Midden-Brabant, GGZ Oost-Brabant, GGZ
   Noord-Midden Limburg, Mondriaan Zorggroep, Prins Clauscentrum Sittard,
   RIAGG Roermond, Universitair Centrum SintJozef Kortenberg, CAPRI
   University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria
   Sint-Truiden, GGZ Overpelt, OPZ Rekem). Supported by the European
   Community's Seventh Framework Program under grant agreement No.
   HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; The authors have the following interest.
   Prof van Os conducts other studies, not related to the study that is the
   subject of the authors' submission and approved by the standing ethics
   committee, that are in part supported by unrestricted grants from
   Janssen-Cilag, Eli Lilly and Co, AstraZeneca, and Lundbeck. This does
   not alter the authors' adherence to all the PLOS ONE policies on sharing
   data and materials.
CR Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0
   Borsboom D, 2012, PLOS ONE, V6
   Collip I, 2011, PSYCHOL MED, V41, P911, DOI 10.1017/S0033291710001558
   Delespaul P. A. E. G., 1995, ASSESSING SCHIZOPHRE
   Derogatis LR, 1977, SCL 90 ADM SCORING P
   Dominguez MDG, 2010, AM J PSYCHIAT, V167, P1075, DOI 10.1176/appi.ajp.2010.09060883
   Freeman D, 2007, CLIN PSYCHOL REV, V27, P425, DOI 10.1016/j.cpr.2006.10.004
   Garety PA, 2001, PSYCHOL MED, V31, P189, DOI 10.1017/S0033291701003312
   Green AS, 2006, PSYCHOL METHODS, V11, P87, DOI 10.1037/1082-989X.11.1.87
   Gurka MJ, 2011, STAT MED, V30, P2696, DOI 10.1002/sim.4293
   Heinrichs R. W., 2001, SEARCH MADNESS SCHIZ
   Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531
   HEMSLEY DR, 1993, BEHAV RES THER, V31, P633, DOI 10.1016/0005-7967(93)90116-C
   Henquet C, 2005, BMJ-BRIT MED J, V330, P11, DOI 10.1136/bmj.38267.664086.63
   Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006
   Hyman SE, 2010, ANNU REV CLIN PSYCHO, V6, P155, DOI 10.1146/annurev.clinpsy.3.022806.091532
   Jacobs N, 2005, LIFE SCI, V76, P2431, DOI 10.1016/j.lfs.2004.10.045
   Jacobs N, 2006, PSYCHOSOM MED, V68, P201, DOI 10.1097/01.psy.0000204919.15727.43
   Jacobs N, 2005, ACTA PSYCHIAT SCAND, V112, P394, DOI 10.1111/j.1600-0447.2005.00588.x
   Jacobs N, 2011, BRIT J CLIN PSYCHOL, V50, P19, DOI 10.1348/014466510X491397
   Jacobs N, 2006, ARCH GEN PSYCHIAT, V63, P989, DOI 10.1001/archpsyc.63.9.989
   Jensen J, 2008, NEUROPSYCHOPHARMACOL, V33, P473, DOI 10.1038/sj.npp.1301437
   Kahn RS, 2011, ARCH GEN PSYCHIAT, V68, P138, DOI 10.1001/archgenpsychiatry.2010.132
   Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13
   Kapur S, 2004, TRENDS PHARMACOL SCI, V25, P402, DOI 10.1016/j.tips.2004.06.005
   KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261
   Kramer IMA, 2012, PSYCHOL MED, V42, P283, DOI 10.1017/S0033291711001474
   Lahera G, 2012, REV PSIQUIATR SALUD, DOI [10.1016/j.rpsmen.2012.05.003, DOI 10.1016/J.RPSMEN.2012.05.003]
   Lardinois M, 2011, ACTA PSYCHIAT SCAND, V123, P28, DOI 10.1111/j.1600-0447.2010.01594.x
   Lataster T, 2009, ACTA PSYCHIAT SCAND, V119, P45, DOI 10.1111/j.1600-0447.2008.01263.x
   Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754
   Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6
   Molenaar PCM, 2009, CURR DIR PSYCHOL SCI, V18, P112, DOI 10.1111/j.1467-8721.2009.01619.x
   Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058
   Myin-Germeys I, 2003, ACTA PSYCHIAT SCAND, V107, P124, DOI 10.1034/j.1600-0447.2003.02025.x
   Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137
   Myin-Germeys I, 2005, BIOL PSYCHIAT, V58, P105, DOI 10.1016/j.biopsych.2005.02.012
   Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179
   Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947
   Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005
   Myin-Germeys I, 2011, SCHIZOPHRENIA BULL, V37, P244, DOI 10.1093/schbul/sbq164
   Nesselroade JR, 2007, MEAS-INTERDISCIP RES, V5, P217, DOI 10.1080/15366360701741807
   Rabe-Hesketh S, 2008, MULTILEVEL LONGITUDI
   Roiser JP, 2009, PSYCHOL MED, V39, P199, DOI 10.1017/S0033291708003863
   Rutter M, 2011, J CHILD PSYCHOL PSYC, V52, P647, DOI 10.1111/j.1469-7610.2011.02367.x
   Simons CJP, 2007, SCHIZOPHR RES, V92, P24, DOI 10.1016/j.schres.2007.01.008
   Simons CJP, 2009, GENES BRAIN BEHAV, V8, P5, DOI 10.1111/j.1601-183X.2008.00434.x
   Smeets F, 2012, SCHIZOPHRENIA BULL, V38, P531, DOI 10.1093/schbul/sbq117
   Spauwen J, 2006, BRIT J PSYCHIAT, V188, P527, DOI 10.1192/bjp.bp.105.011346
   StataCorp, 2011, STATA STAT SOFTW REL
   van Os J, 2009, ACTA PSYCHIAT SCAND, V120, P363, DOI 10.1111/j.1600-0447.2009.01456.x
   van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563
   van Os J, 2009, LANCET, V374, P635, DOI 10.1016/S0140-6736(09)60995-8
   van Rossum I, 2011, SCHIZOPHRENIA BULL, V37, P561, DOI 10.1093/schbul/sbp101
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482
   Wechsler D., 2001, WECHSLER ADULT INTEL
   Wichers M, 2011, ACTA PSYCHIAT SCAND, V123, P402, DOI 10.1111/j.1600-0447.2011.01684.x
   Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x
   Wichers M, 2010, J AFFECT DISORDERS, V124, P191, DOI 10.1016/j.jad.2009.11.010
   Wichers M, 2009, PSYCHOL MED, V39, P1077, DOI 10.1017/S0033291708004388
   Wichers MC, 2009, NEUROPSYCHOPHARMACOL, V34, P923, DOI 10.1038/npp.2008.66
   Wichers M, 2008, J ABNORM PSYCHOL, V117, P699, DOI 10.1037/a0012909
   Wichers M, 2007, BRIT J PSYCHIAT, V191, P218, DOI 10.1192/bjp.bp.106.032201
   Wichers M, 2012, HEALTH PSYCHOL, V31, P135, DOI 10.1037/a0025688
   Wichers MC, 2007, ACTA PSYCHIAT SCAND, V115, P451, DOI 10.1111/j.1600-0447.2006.00924.x
   Wigman JTW, 2011, AM J MED GENET B, V156B, P546, DOI 10.1002/ajmg.b.31193
NR 67
TC 24
Z9 25
U1 0
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 15
PY 2013
VL 8
IS 2
AR e54653
DI 10.1371/journal.pone.0054653
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 099EQ
UT WOS:000315603700006
PM 23457452
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

EF